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ABSTRACT 
High throughput DNA sequencing has emerged as a versatile and 
inexpensive readout of functional activity in biological organisms. In this study I 
describe the implementation of DNaseI hypersensitivity assays using deep 
sequencing (DNase-seq) to systematically identify Caenorhabditis elegans 
cis-regulatory modules (CRMs) in embryonic and L1 arrest larval life stages in an 
unbiased and de novo manner. We validated our data by comparison to many 
known enhancers of lin-39/ceh-13 Hox complex and of hlh-1, myo-2, myo-3, 
lin-26, and other important developmental genes and are also able to predict 
novel cis-regulatory modules. We predict novel regulatory motifs from our 
DNase-seq data and predict potential regulatory functions using gene ontology 
and anatomy enrichment analysis. In addition, our data are high-resolution 
enough to identify binding sites of transcription factors in the genome. Our data 
provide support for many distal CRMs in C. elegans and for a significant portion 
of genes possessing multiple CRMs. DNase-seq data can also be used to refine 
prediction of tissue-specific genes such as those regulated by C. elegans 
pan-neuronal N1 and intestinal ELT-2 DNA motifs.  Overall, we identify 24,128 
putative CRMS containing over 55,000 footprints. In L1 arrest, we identify 15,841 
putative CRMs in the L1 arrest larvae containing 32,000 TF footprints. From 
comparison of these datasets, we identify an additional 1,854 noncoding DHS 
that appear to be specific to the L1 arrest larvae condition. These genes include 
downstream targets of signaling pathways known to be regulated during L1 arrest 
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such as insulin-like signaling via DAF-16/FOXO and Forkhead box 
transcription factor PHA-4/FOXA that impacts starvation survival in the L1 
arrest condition.  Having established the first proof-of-principle DNase-seq in 
nematodes using C. elegans, I am applying DNase-seq to a distantly related 
entomopathogenic nematode, Steinernema carpocapsae, with a recently 
sequenced genome and transcriptome. Finally, I am using a massively parallel 
reporter assay to test the functional activity of the CRMs we have discovered from 
DNase-seq using two reporter designs based on MPRA and STARR-seq and by 
performing DNA and RNA sequencing on transgenic C. elegans. 
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NOMENCLATURE 
Transcription Factor (TF). Proteins with a DNA binding domain that binds to 
specific sequences and can regulate target gene expression through activation or 
repression. 
Cis-regulatory module (CRM). Genomic DNA sequence that contains binding 
sites for transcription factors and that regulates transcription of target genes on the 
same chromosome. 
Enhancer. Orientation-independent CRM that can act at a distance to upregulate 
target gene expression. 
DNaseI. Nuclease that cuts DNA preferentially in nucleosome-free regions and 
with relatively low sequence specificity 
DNase-seq. Experimental technique that measures cleavage patterns in 
chromatin by DNaseI using high throughput sequencing to discover CRMs and TF 
binding sites. 
DNase Hypersensitive Site (DHS). Genomic DNA sequence (roughly several 
hundred base pairs in length) that has been found to exhibit significantly increased 
DNaseI cleavage. 
Noncoding DHS. DHS that have been annotated in non-coding regions of the 
genome and represent putative cis-regulatory modules (CRMs). 
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TF Footprint. In the context of DNase-seq, stretches of genomic DNA sequences 
between 6-40bp within noncoding DHS that show significantly lower read 
coverage and strand-shift in mapped reads and represent putative binding sites for 
TFs. 
ChIP-seq. Experimental technique that detects binding sites for TFs using 
protein-DNA crosslinking, chromatin immunoprecipitation using antibodies 
against TFs of interest, and high throughput sequencing. 
ATAC-seq. Experimental technique that uses Tn5 transposase integration of 
sequencing primers and high throughput sequencing to discover CRMs and TF 
binding sites. 
Gene Ontology. Terms within a controlled vocabulary to describe characteristics 
of gene products in the domains of cellular localization and biological function. 
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C h a p t e r  1  
Evolving approaches to the discovery of cis-regulatory elements and 
transcription factor binding sites in Caenorhabditis elegans and other 
metazoans 
Introduction 
Approaches to discover and characterize cis-regulatory modules (CRMs) in 
diverse model organisms have evolved and improved greatly in the last decade, 
enabling high throughput analysis and characterization of functional activity of 
noncoding sequences in eukaryotic genomes. In this chapter I will review methods in 
this field of research from the perspective of trying to apply these methods to study 
C. elegans transcriptional regulation. The central question guiding this review and 
my thesis is: How can we systematically identify and characterize CRMs and their 
regulatory functions? I will examine this question through the lens of historical 
approaches in the field and more recent methods that use sequencing as a read out 
of chromatin accessibility, TF binding, and functional activity.  
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The nematode Caenorhabditis elegans as a model for studying 
transcriptional regulation and development 
Nematodes represent a diverse phylum and are increasingly well-studied, not 
in small part due to the rapidly decreasing costs of sequencing entire nematode 
genomes (Dillman et al. 2012; Sommer  and Streit et al. 2011; Kumar et al. 2012). 
The genetically best-studied nematode species is Caenorhabditis elegans, with one 
of the best annotated and complete metazoan genome sequences containing some 
20,431 protein-coding genes (Hillier et al. 2005). C. elegans presents a fruitful 
system in which to study transcriptional gene regulation in the context of 
development and evolution. The embryonic and larval development of C. elegans is 
well-studied and large populations of individuals are easy to grow and synchronize 
in liquid culture, making it easy to isolate large amounts of chromatin from worms at 
distinct life stages (e.g Baugh et al. 2009; Figure 1.1). Studies of cis-regulation in C. 
elegans have given us insight into mechanisms of transcriptional regulation during 
development from the rapid activation of growth genes following recovery from 
developmentally arrested states mediated by RNA polymerase II pausing (Baugh et 
al. 2009) to the cis-regulatory architecture involved in specification of cell fates 
(reviewed by Maduro et al. 2010). 
Studying C. elegans transcription has some unique considerations due to 
trans-splicing of mRNA transcripts. Around 70% of C. elegans transcripts are 
known to be trans-spliced, wherein the RNA transcript containing a 3’ splice site is 
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spliced to an SL1 or SL2 splice leader sequence (Krause and Hirsch, 1987; reviewed 
in Blumenthal et al. 2012). As a result, the transcription start sites (TSS) of 
C. elegans are not easily defined with conventional RNA-seq methods. Fortunately, 
recent studies have used 5’capped nuclear RNA sequencing (Chen et al. 2013) and 
similar GRO-cap sequencing (Kruesi et al. 2013) to generate TSS maps for 
C. elegans. Also of note is that >17% of C. elegans genes are present in operons 
(Allen et al. 2011). Genes in operons are transcribed together as a polycistronic 
primary transcript and processed by splicing machinery to generate multiple 
messenger RNA transcripts (Blumenthal 2004; reviewed in Blumenthal 2012). 
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1 http://www.wormatlas.org/ 
 
Figure 1.1 The life cycle of Caenorhabditis elegans (WormAtlas1) 
C. elegans is fast growing, with a lifecycle of ~2.5 days. An embryo undergoes about 11 hours of 
development to hatch. L1 larvae will arrest in the absence of available food. In the presence of food, 
L1 larvae will proceed to L2, but can be diverted to pre-dauer L2d in conditions of crowding, 
starvation and high temperature. L2 larvae will develop normally into L3, L4, and then into a 
reproductive adult. 
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Cis-regulatory modules during development and the function of 
enhancers  
The control of gene expression during development is critically dependent on 
the binding of transcription factor proteins to cis-regulatory modules (CRMs) in the 
genome to regulate transcription of target genes (Figure 1.2; reviewed in Noonan 
and McCallion et al., 2010; Borok et al. 2010). In the case of enhancers, which were 
first discovered in the SV40 simian virus as sequences that could drive the 
transcription of adjacent genes in an orientation-independent manner (Banerji et al. 
1981; Benoist and Chambon, 1981), the binding of activator TFs to specific DNA 
motifs triggers recruitment of RNA polymerase II and drives transcription of the 
target gene according to specific spatiotemporal patterns. Repressor TF binding sites 
within the enhancer help to restrict spatiotemporal pattern of expression. Other 
CRMs such as silencers specifically block expression of target genes by binding 
repressor TFs or chromatin remodeling proteins such as Polycomb (Zhang and 
Bienz, 1992; Sengupta et al. 2004; reviewed in Ogbourne and Antalis, 1998). In 
Drosophila and mammals, insulators are a type of CRM that blocks transcription of 
a target gene in specific orientation (Kellum and Schedl, 1991; reviewed in Gaszner 
and Felsenfeld, 2007). Other examples of CRM types are the locus control regions 
(LCR), most notably in the β-globin locus and promoter tethering elements in the 
Drosophila bithorax complex (BX-C) (Akbari et al. 2008; Ho et al. 2011; Kwon et al. 
2009). 
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Figure 1.2 Major types of CRMs found in eukaryotes 
Promoters (green) bind RNA Pol II and the basal transcription machinery to direct transcription. 
Enhancers (orange; which bind TFs) can act at a distance to upregulate target gene expression. 
Silencers (blue; which bind TFs) can also act at a distance to downregulate target gene expression. 
Insulators (black) can act either as enhancer blocking (EB) element or as a barrier to 
heterochromatin spread. Figure redrawn from Noonan and McCallion 2010. 
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In order to identify and study CRMs, it greatly helps to understand how they 
are situated within the context of the chromosome. In the nucleus, the DNA on 
chromosomes is wound around roughly 146bp of core histone octamer and packaged 
into nucleosomes (Kornberg 1977). Condensation of DNA into nucleosomes allows 
approximately 2 meters of DNA to be packaged into chromatin in the space of only a 
few microns in diameter. Regulation of the higher order structure of this chromatin 
is a complex process in three-dimensional space that renders parts of the DNA 
accessible or inaccessible to binding by DNA binding proteins such as transcription 
factors, RNA polymerase, and other chromatin-regulatory factors (Figure 1.3; 
reviewed in Cockerill 2011). Promoter and enhancer CRMS are often found in 
relatively nucleosome-free regions of the genome that are accessible to binding by 
TFs and other transcriptional machinery (reviewed in Shlyueva et al. 2014). 
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Many TFs use cooperativity in order to bind target binding sites in CRMs on 
nucleosomes (reviewed in Mirny 2010), but a subset of TFs, the pioneer TFs, are able 
to bind independently to nucleosomes and they do so earlier than most TFs 
(reviewed in Zaret and Carroll 2011). TF binding to target sites is not explained 
entirely by DNA sequence motifs (reviewed in Shlyueva et al. 2014) but also by local 
sequence features such as GC content (White et al. 2013) and perhaps also 
chromatin accessibility.  
 
Figure 1.3 Chromatin as an accessibility barrier to binding by DNA-binding proteins to 
sequences such as enhancers and promoters. 
CRMs such as enhancers (orange box) and promoters (green box) tend to be in relatively 
nucleosome-free regions where TFs (yellow and green ovals and blue hexagons) are able to access 
and bind to specific DNA binding motifs  and recruit other DNA-binding proteins such as RNA 
polymerase II (red complex). 
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Additional factors help recruit TFs and transcriptional machinery to CRMs. 
These include CBP-1/P300 transcriptional activator (Visel et al. 2009) and the 
histone modification H3K4 methylation (Heintzmann et al 2007; Mikkelsen et al. 
2007). Locations of these epigenetic marks have been used to locate enhancers (He 
et al. 2010). However, there is no consensus about exactly which marks are suitable 
and not all enhancers have marks (reviewed in Shlyueva et al. 2014).  
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Identifying CRMs using sequence conservation and limitations of 
these approaches 
The gold standard method of testing enhancers has been to individually test 
sequences using a transgenic construct to determine whether these sequences are 
able to drive expression of a reporter gene such as lacZ or GFP (Figure 1.4).  
 
Figure 1.4 Testing enhancers for functional activity using transgenic reporter assays in 
C. elegans and Drosophila. Figures adapted from Ho et al. 2009; Kuntz et al. 2008. 
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Systematic interrogation of the genome by individually testing enhancers in 
transgenic reporter assays is laborious, requiring the cloning and injection of 
individual constructs for each test sequence. Having said that, systematic analysis 
has been performed for some large complex loci such as the C. elegans lin-39/ceh-13 
Hox locus (Kuntz et al. 2008) and the Hox genes in Drosophila BX-C (reviewed in 
Akbari et al. 2006 and Borok et al. 2010). Detection of CRMs in the C. elegans study 
by Kuntz et al. was greatly aided by the sequencing of many related Caenorhabditis 
species, allowing comparison of orthologous genomic sequences between species to 
identify regions exhibiting high sequence conservation, in an approach that is 
sometimes called phylogenetic footprinting. Kuntz and colleagues validated these 
conserved sequences as enhancers by testing them in transgenic reporter gene assays 
(Figure 1.4). The rationale behind this approach is that functional sequences such as 
regulatory sequences or protein-coding sequences are more likely to be conserved 
compared to genomic background because changes to these important sequences are 
likely to disrupt functional activity. This has been an approach that has helped to 
find many CRMs in C. elegans (e.g. Kirouac and Sternberg 2003; Wenick and 
Hobert 2004; Puckett-Robinson et al. 2013). 
There are still many limitations to using sequence conservation since 
cis-regulatory sequences may not necessarily display increased sequence 
conservation compared to genomic background (Ho et al. 2009). Despite this lack of 
sequence conservation, orthologous enhancers from distantly related species have in 
many cases continued to function even after significant evolutionary sequence 
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change (Hare et al. 2008; Ho et al. 2009). This appears to be due to conservation 
of TF binding site clusters and some flexibility in secondary binding sites, allowing 
sequences surrounding TF binding sites in the enhancer to change. Furthermore, at 
least in Drosophila, virtually all of the noncoding sequence can be considered 
conserved and so identifying regulatory elements based solely on sequence 
conservation is rather difficult (Peterson et al. 2009)  
 Algorithms to find clusters of TF binding sites have had some success in 
helping to predict the location of CRMs (Berman et al. 2002; Starr et al. 2011; 
Davidson et al. 2002; reviewed in Wasserman and Sandelin, 2004 and Su et al. 
2010) but this is possible only if DNA binding motifs for TFs have been characterized 
beforehand and if activator and repressor TFs have been well defined for a particular 
locus or set of genes, as has been the case for well studied systems such as the 
Drosophila BX-C (Starr et al. 2011) and sea urchin endoderm gene regulatory 
network (Yuh et al. 1998). 
Regardless, approaches relying solely on sequence conservation (Kuntz et al. 
2008) or TF binding sites are still associated with significant false positives and 
negatives and better understanding of the constraints on sequence and function will 
likely help improve prediction of additional CRMs (Figure 1.5). Furthermore, there is 
a great need to increase the number of enhancer CRMs that are well-characterized. 
High throughput methods to identify and test CRMs would aid greatly in this 
endeavor. 
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Probing TF binding and chromatin accessibility with high-throughput 
sequencing: ChIP-seq, DNase-seq, FAIRE, ATAC-seq 
Approaches utilizing high-throughput DNA sequencing technology to assay 
TF regulatory inputs and RNA output allow the investigation of cis-regulation 
genome wide (reviewed in Tsompana and Buck 2014). Studies of chromatin 
immunoprecipitation (ChIP) with antibodies against transcription factors of interest 
to isolate DNA bound by those TFs allows the measurement of TF binding sites in 
the genome (Ren et al. 2000; Johnson et al. 2007). Data from these ChIP-chip 
(wherein DNA is hybridized to microarrays) and ChIP-seq (wherein DNA is 
sequenced) studies can be mined to detect CRMs (Visel et al. 2009). 
In C. elegans, ChIP-seq studies have helped identify binding sites for over 100 
TFs of interest and the locations of chromatin regulatory marks such as H3K4 
methylation, H3K27 acetylation, etc. (Araya et al. 2014; Zhong et al. 2010; Gerstein 
et al. 2010; Kuntz et al. 2012) as well as the transcriptional machinery of RNA 
polymerase II (Baugh et al. 2009). ChIP-seq is limited by the availability of high 
quality antibodies or GFP-tagged TFs of interest. Interestingly, not all TF sites bound 
in ChIP-seq are functional enhancers, raising the question of what, other than TF 
binding, determines the functional activity of sequences.  This may be due to the 
need for cooperative binding of TFs, or local chromatin context such as histone 
marks and chromatin accessibility. 
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It has been known since the early 1980s that DNaseI, a nuclease with relatively low 
sequence specificity, will cut based on chromatin accessibility and thus preferentially 
in nucleosome-free CRMs (Gross and Garrard, 1988; reviewed in Cockerill et al. 
2010). In fact, the CRMs of the β-globin locus were discovered using DNaseI 
hypersensitivity assays (Fraser et al. 1993; Tuan et al. 1985), and early studies 
showed that chromatin domains containing actively transcribed genes are at least 
twice as accessible to nuclease digestion as inactive genes (reviewed in Cockerill et al. 
2011). Other older footprinting assays used chemicals such as potassium 
permanganate (KMnO4) and dimethyl sulfate (DMS) to identify CRMs, based on 
selective oxidation of single-stranded thymine and differential methylation of 
guanine bound or unbound by TFs, respectively, but these are not scalable (Spicuglia 
et al. 2004; Drouin et al. 1997). Compared to earlier methods measuring footprinting 
in specific loci using northern blots, it possible to treat chromatin with DNaseI and 
size select and sequence the shortest fragments and measure chromatin accessibility 
over the entire genome in a method called DNase-seq (Figure 1.5; Hesselberth et al 
2009; Thurman et al. 2012). Two methods of DNase-seq have been described (Boyle 
et al. 2011; Hesselberth et al. 2009), with the double-hit protocol from the 
Stamatoyannopoulos lab being primarily used by ENCODE (Consortium 2012). 
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TF binding within a CRM can also be detected in DNase-seq data. Within 
larger regions (hundreds of base pairs) showing DNaseI hypersensitivity (high read 
coverage), the presence of TFs will protect smaller regions (6-40bp) from being cut 
by DNaseI (low read coverage) and also cause a strand-shift in read coverage (Figure 
1.6). An example of DNase-seq data from the C. elegans embryo is shown in Figure 
1.7. 
 
Figure 1.5 DNase-seq schematic. 
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Figure 1.6 Strand shift in reads in ChIP-seq and DNase-seq due to TF binding. 
Sequencing by synthesis occurs in a 5’ to 3’ direction, yielding reads that align on opposite strands on 
either side of a bound TF (figure adapted from Park et al. 2009). Aligning reads from each strand 
results in peaks that flank the TF binding site. 
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Figure 1.7 Example of DNase-seq data 
Total DNaseI signal (red) can be separated in to positive (light orange) and negative strands (green). 
One noncoding DHS (light blue) and several TF footprints (dark blue) were found overlapping two 
noncoding transcripts (brown) between two embryo-expressed genes rab-11.1 and rpl-7 (black with 
arrows). Existing comparison data from modENCODE (Gerstein et al. 2010) shows ChIP peaks of 
RNA Pol II (dark red), H3K4me3 (pink), a highly occupied TF region (yellow, indicates more than 15 
TFs binding) and TSS data from Chen et al. 2013 (dark orange). Conservation track across seven 
Caenorhabditis species is shown in dark blue and MULTIZ conserved elements in magenta. 
 
The depth of sequencing required to probe chromatin accessibility depends 
on the desired features to be captured. TF footprinting with DNase-seq requires a 
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higher depth of sequencing. Paired end or long reads are often preferred in 
genomes where there are many repeat elements or there is low complexity. However 
short read sequencing, which is less expensive, is often sufficient for chromatin 
accessibility studies (reviewed in Tsompana and Buck, 2014). 
A similar method to DNase-seq, formaldehyde-assisted identification of 
regulatory element elements (FAIRE) can be used to make regulatory maps using 
formaldehyde crosslinking followed by phenol-chloroform extraction to isolate 
nucleosome-depleted regions in the aqueous layer for sequencing (Giresi et al. 2007; 
Giresi and Lieb 2009). FAIRE suffers from low signal to noise ratio and it does not 
provide the resolution needed to identify TF footprints within CRMs. Studies 
comparing DNase-seq and FAIRE show strong-cross-validation of putative CRMs 
identified (Song et al. 2011). FAIRE, being an orthogonal study, can still be useful to 
validate some DNase-seq results. 
Another promising alternative to DNase-seq is transposase-accessible 
chromatin using sequencing, also known as ATAC-seq. ATAC-seq utilizes a Tn5 
transposase to insert sequencing primers into the genome based on chromatin 
accessibility. In comparison to DNase-seq, several thousand cells are needed instead 
of 100,000 cells required for DNase-seq. ATAC-seq involves only two steps: Tn5 
insertion followed by PCR (Buenrostro et al. 2013), and therefore reduces loss of 
sample material from gel extraction and adaptor ligation needed in DNase-seq. 
Maps of chromatin accessibility from ATAC-seq can be equal or close to the quality 
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of DNase-seq and can also provide maps of nucleosome positioning near regions 
of accessibility. 
Investigating TF footprinting in chromatin accessibility studies 
Several recent TF footprint detection methods have been developed that use 
similar underlying statistical methods to detect lower read coverage and strand shift 
in reads indicative of TF binding sites. The Wellington algorithm (Piper et al. 2013) 
detects significantly lower read coverage in a region within a DHS compared to 
positive and negative shoulder regions of varying shoulder lengths and tests the null 
hypothesis that the number of reads in the footprint region is proportional to region 
length. P-values are then calculated for the footprints and TF footprints are chosen 
on the basis of a p-value threshold.  
A more recent method, DNase2TF, has been shown to improve accuracy and 
sensitivity, and also provide a greater number of TF footprints when tested against 
orthogonally derived ChIP-seq TF binding sites using receiver-operating 
characteristic (ROC) curves (Sung et al. 2014). DNase2TF works by measuring cut 
count within a DHS and then adjusts the cut count by dinucleotide frequency bias 
(measured from the DNaseI sample) and mappability using measures of read 
mappability generated by PeakSeq (Rozowsky et al. 2009). Cut count depletion 
(indicating TF protection) is measured and modeled with a binomial distribution to 
assess the significance of local depletion with a z-score. This z-score compares cut 
count in the candidate region and in a surrounding window that is three times the 
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size of the region. The more the candidate region is depleted of cutting, the lower 
its z-score and the greater its depth of TF protection. Footprints are merged if 
comparing the z-score between consecutive footprints shows that the z-score of the 
combined region is better than the individual regions. The location of reads mapping 
within each DHS are randomized, allowing an estimation of the false discovery rate 
(FDR) and a threshold z-score.  
An important consideration in the analysis of DNase-seq has been raised by 
Sung and colleagues (2014). They found that, contrary to previous reporting of low 
sequence specificity for nuclease digestion by DNaseI, there is some DNaseI 
sequence specificity that impacts the observed profile of footprints for a given TF or 
sequence, and this is not dependent on TF-DNA contacts as was previously reported 
(Hesselberth et al. 2009). Instead, it appears critical that TF footprints are called on 
 
Figure 1.8 DNaseI profiles are composed of two components: Protection from 
transiently bound TF and DNA-cut signature. 
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the basis of protection depth and not on their specific nucleotide-level cut 
signatures (Figure 1.8). These nucleotide-level cut signatures are in fact dependent 
on the use of DNaseI as the cutting nuclease and can be predicted by measuring and 
modeling the dinucleotide cut preferences of nucleases on naked DNA (Sung et al. 
2014). This is likely also to prove an important caveat to similar analyses using 
ATAC-seq since it seems likely that no accessibility method is entirely immune to 
sequence bias.  
Importance of the transgenic functional assay and need for higher 
throughput assays 
Transgenic reporter assays continue to be the gold standard test for testing 
cis-regulatory activity, but new approaches using high throughput sequencing are 
enabling parallel testing of enhancers. Parallel assays have been previously described 
that use sequencing (Nam and Davidson 2012) and/or fluorescence-activated cell 
sorting (FACS) methods to test enhancers in bulk (Gisselbrecht et al. 2013; Dickel et 
al 2014). 
In enhancer FACS-seq, libraries of putative enhancers are cloned upstream of 
fluorescent reporter genes and these constructs are injected to generate transgenic 
organisms. Dissociated cells from the transgenic organisms are selected for the 
fluorescent transgene with FACS and sequenced in order to determine active 
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enhancer sequences (Gisselbrecht et al. 2013). Additional fluorescent reporters or 
specific cell-surface markers can be expressed to allow cell or tissue-specific sorting. 
Another similar method called SIF-seq uses single-copy site-specific 
integration of putative enhancer libraries cloned upstream of a reporter gene with 
FAC-sorting and sequencing to test enhancer CRMs. Both these methods are 
effective but require the additional step of FAC sorting which may limit throughput.  
Hundreds of CRMs were tested in the case of eFS, whereas the use of fragmented 
BAC constructs in SIF-seq limited them to specific gene loci. These techniques are 
nevertheless still promising. 
The use of custom oligo libraries traditionally used in the synthesis of 
microarrays to generate test sequences tagged with unique barcodes and distinct 
amplification primers have opened the doors to studies (MPRA and FIREWACh) 
testing many tens or hundreds of thousands of enhancers for functional activity 
(Melnikov et al. 2012; Murtha et al. 2014). Custom oligos are synthesized as a 
mixture and primers can be designed to amplify subsets of the oligo library. Using 
custom oligo library technology, parallel reporter assay constructs are designed such 
that a unique barcode (included in the oligo sequence) is expressed when the 
putative CRM (also on the custom oligo) is able to drive expression. Testing 
sequences for functional activity is accomplished by transfecting oligo library 
constructs into cell lines, and then simultaneously collecting RNA and genomic DNA 
to be sequenced using RNA-seq and DNA sequencing.  Detection of unique barcodes 
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in RNA-seq expression can therefore indicate that the sequence that is uniquely 
associated with the barcode is able to function as an enhancer. DNA sequencing 
enables the RNA-seq expression data to be normalized by the amount of transgene 
that is successfully transfected into cells. Thousands of enhancer sequences can thus 
be screened in a single experiment and, if found to direct expression in the 
sequencing data, they can be selected for further characterization in single transgene 
assays. Furthermore, using custom oligos allows for mutagenesis and manipulation 
of any part of the enhancer sequence to be tested (for example, mutations in TF 
binding sites) allowing analysis of enhancer function. 
Another variation, STARR-seq, has the candidate sequence being tested for 
enhancer activity cloned downstream of the reporter gene, so that it is also 
transcribed (Arnold et al. 2013). This sequence is then detectable in the RNA-seq 
expression data. This can mitigate the need to have barcodes to distinguish each 
enhancer sequence (Figure 1.9). In this case, thousands of potential enhancers are 
isolated for cloning using genomic fragmentation. Application of a massively parallel 
reporter assay to C. elegans using transgenesis yielding extrachromosomal arrays is 
promising and would open up the system to large comparative studies of CRM 
function. 
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Comparative genomics of nematodes  
Comparisons of enhancer CRMs in different species are useful to study their 
function and evolution, and thus the study of C. elegans transcriptional regulation 
will undoubtedly benefit from more comparisons with related species in the 
nematode phylum. To date, more than 80 nematode genomes have been published 
 
Figure 1.9 STARR-seq experimental design and resulting enhancer maps 
Libraries of putative enhancers (purple, light blue, yellow) were isolated by genomic fragmentation 
and cloned downstream of GFP reporter. Once construct libraries are transfected in S2 cells, DNA 
and poly-A RNA are isolated and sequenced. The resulting STARR-seq of the RNA reads (dark blue) 
shows representation of the enhancer sequences, indicating sequences are able to drive reporter 
expression. 
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(according to WormBase ParaSite2), including some with transcriptome profiles by 
RNA-seq, which enables the annotation of protein-coding genes. The diversity of 
species being sequenced from all nematode clades represents a rich genomic toolkit 
with which to investigate nematode development, evolution, and behavior, especially 
as these nematodes have diverse ecology and lifestyles, ranging from free-living to 
parasitic, and reach evolutionary distances that span hundreds of millions of years 
(Dillman et al. 2012). Much of the comparative analysis of nematode genomes has 
focused on protein coding genes, such as protein families that appear to have 
expanded in the genomes of parasites and may play a role in host infection (Dillman 
et al. 2012; Dillman et al. 2013). However, future studies that delve into the 
noncoding regions of these genomes are likely to yield fascinating insights into the 
mechanism of regulation of important genes.  
Evolution of the Hox gene complex and cis-regulatory elements in 
nematodes 
The Hox genes are an ancient regulatory protein family and are involved in 
regulating critical developmental process across metazoans. Hox gene regulation has 
been studied by researchers over many decades (McGinnis et al. 1984; Lewis et al. 
1978; reviewed in Pearson et al. 2005). Hox gene complexes have been studied 
across several nematodes, showing striking loss and sequence turnover compared to 
other metazoans (Aboobaker and Blaxter, 2003a,b). Among closely related 
                                                 
2 http://parasite.wormbase.org 
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Caenorhabditis species, sequence conservation has been used successfully to 
identify CRMs such as those from lin-39/ceh-13 (Kuntz et al. 2008). The latest data 
from Steinernema genomes show that many of the Hox genes present in C. elegans 
are also present in members of the Steinernema genus (Dillman, Macchietto et al. 
submitted; Figure 1.10). However, many additional unrelated protein-coding genes 
appear to be inserted between the Hox genes lin-39 and ceh-13, increasing the 
intergenic distance to more than 40 kb. It remains to be seen whether the cis-
regulatory regions found by Kuntz et al. (2008) in C. elegans are conserved in other 
nematodes such as those in Steinernema genus. 
Improving our knowledge of cis-regulation in C. elegans and other nematodes 
will help to address questions about function and flexibility in the evolution of 
 
Figure 1.10 Nematode Hox gene clusters (Adapted from Dillman, Macchietto et al. submitted) 
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CRMs. The more examples that we have of characterized CRMs in C. elegans and 
other nematode species, the better we are able to understand the underlying 
mechanisms of CRM function, evolutionary change, and species diversity. 
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Genome-wide discovery of active regulatory elements and transcription 
factor footprints in Caenorhabditis elegans embryos and L1 arrest 
larvae using DNase-seq 
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Abstract 
Deep sequencing of size-selected DNaseI-treated chromatin (DNase-seq) 
allows high resolution measurement of chromatin accessibility to DNaseI cleavage, 
permitting identification of de novo active CRMs and individual TF binding sites. 
We adapted DNase-seq to nuclei isolated from C. elegans embryos and L1 arrest 
larvae to generate high-resolution maps of TF binding. Over half of embryonic 
DNaseI hypersensitive sites (DHS) were annotated in noncoding sequences, with 
23% in intergenic, 11% promoter regions and 21% in introns, with similar statistics 
in L1 arrest data. Noncoding DHS exhibit high evolutionary sequence conservation 
and are enriched in marks of enhancer activity and transcription. We mined the 
data to identify putative active CRMs, TF footprints, and 57 novel cis-regulatory 
motifs. We validated noncoding DHS against a previously investigated set of 
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enhancers from lin-39/ceh-13, myo-2, myo-3, hlh-1, elt-2 and lin-26/lir-1 gene 
loci and were able to recapitulate 22 of 29 known enhancers and predict novel 
CRMs. Our DNase-seq data was able to improve predictions of tissue-specific 
expression compared to motifs alone. Overall, we provide experimental annotation 
of 26,644 putative CRMs in the embryo containing 55,890 TF footprints, and 
15,841 putative CRMs in the L1 arrest larvae containing 32,685 TF footprints. 
Comparative analysis shows 1,854 condition-specific DHS in L1 arrest, 
representing putative CRMs of genes targeted by DAF-16 and PHA-4 and which 
respond to starvation.  
Keywords: cis-regulatory modules, gene regulation, enhancers, nematode 
development, transcription, DNase, hypersensitivity  
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Introduction 
Prior research in metazoans has described several important types of cis-
regulatory modules (CRMs) such as enhancers, repressors and insulators that can 
be located far from target genes (reviewed in Noonan and McCallion 2010). 
Enhancers upregulate expression of target gene(s) in a specific spatiotemporal 
pattern during development. Repressors restrict expression of target gene(s). 
Insulators act in a direction-dependent manner to block inappropriate target gene 
expression and/or block spreading of heterochromatin. These CRMs are thought to 
function by action of sequence-specific transcription factor (TF) binding which 
helps recruit RNA polymerase II to the target gene in the case of enhancers or 
prevent its association in the case of repressors. Enhancers may serve to recruit 
RNA polymerase II to target genes by physical association with promoters of target 
genes (reviewed in Bulger and Groudine 2010; Krivega and Dean 2012). 
The nematode Caenorhabditis elegans has a well-annotated genome, well-
studied development and many genetic tools available (Harris et al. 2014; Boulin 
and Hobert 2012). C. elegans provides an excellent case to study transcriptional 
regulation within a multicellular organism, especially as it is easy to collect 
synchronized populations of worms in distinct developmental stages (e.g. Baugh et 
al. 2009). 
Rapid establishment of cell fate is transcriptionally regulated during 
C. elegans embryogenesis, as most cell lineages are determined by the 51-cell stage, 
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shortly after eggs have been laid (Edgar 1992). Studies of early embryonic 
transcription regulation have described a mid-blastula transition that occurs 
shortly before this period, around the 26-cell stage, when transcription transitions 
from maternal to zygotic (Baugh et al. 2003) and where embryonic control is 
underway by the 40-cell stage after initiation of gastrulation. At the end of 
embryogenesis, the hatched larva has 558 cells (Sulston et al. 1983). When 
C. elegans L1 larvae hatch in the absence of food, they remain in a developmentally 
arrested state that is resistant to environmental stress (reviewed in Baugh, 2013).  
Developmental arrest of L1 depends on the insulin-like signaling (IlS) pathway of 
C. elegans (Baugh and Sternberg 2006). Mutants strongly defective in the sole 
insulin receptor of C. elegans, daf-2, are L1 arrest constitutive (Gems et al. 1998), 
while mutants of the downstream transcriptional effector of the insulin-like 
signaling pathway, daf-16, result in defects in L1 arrest and reduce survival of 
worms when subjected to starvation (Munoz and Riddle 2003; Baugh and 
Sternberg 2006). In addition, starvation survival of L1 arrest worms is dependent 
on the Tor signaling pathway of C. elegans, resulting in changes in gene expression 
mediated by the transcription factor Forkhead/PHA-4 (Zhong et al. 2010). The 
C. elegans embryo and L1 arrest larvae thus provide interesting conditions in 
which to examine the control of transcription during development. 
A number of enhancer CRMs have been characterized in C. elegans, of 
which many are located close (less than 2 kb away) to the promoter of the target 
gene (e.g. Okkema and Krause 2005). This preponderance of closely-located 
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enhancers is likely due to experiments focusing mostly on promoter-proximal 
regions of genes. A few studies have identified more distantly located CRMs 
(reviewed in Gaudet and McGhee 2010). These include AIY-dependent enhancers 
located in the intron of the neighboring gene or 6kb upstream of the target gene 
(Wenick and Hobert 2004), the CHE-1 binding site 5kb upstream of cog-1 
(O’Meara et al. 2009) identified through a forward mutagenesis screen, and the 
TRA-1 repressor element located 6 kb downstream of egl-1 (Conradt et al. 1999). 
Studies of the lin-39/ceh-13 Hox locus have also identified many distant enhancers, 
such as N7, located 7kb away from its target gene lin-39, and N2, N3, N4 enhancers 
located 18-20kb away from their target ceh-13 (Kuntz et al. 2008). Systematic 
identification of C. elegans CRMs as a whole has proved difficult, since most 
studies have focused on identifying noncoding regions that are conserved on the 
sequence level and individually testing for functional activity in reporter assays. 
ChIP-seq can be used to measure binding of a specific TF of interest to the 
genome (Robertson et al. 2007; Visel et al. 2009; Ren et al. 2000). ChIP-seq in 
C. elegans (e.g. Baugh et al. 2009; Kuntz et al. 2012; Araya et al. 2014; Gerstein et 
al. 2010; Zhong et al. 2010; Niu et al. 2011) has generated data can be mined to 
identify CRMs regulated by TFs of interest; nevertheless a general view of 
simultaneous TF binding in the genome that allows the discovery of CRMs and 
regulatory motifs de novo, without prior knowledge of TFs and need of specific 
antibodies or GFP-tagging, is desirable in C. elegans. 
Hypersensitivity to cleavage by DNaseI has been long known as a property 
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of active cis-regulatory regions (Gross and Garrard 1988). CRMs of the β-globin 
locus, including the locus control region and insulators, were discovered through 
DNaseI hypersensitivity assays (Fraser et al. 1993; Tuan et al. 1985). Studies in 
yeast, mammals, Drosophila, and Arabidopsis have utilized deep sequencing of 
DNaseI-treated chromatin to map protein-DNA interactions de novo (Hesselberth 
et al. 2009; Boyle et al. 2011; Thomas et al. 2011; Song et al. 2011; Sullivan et al. 
2014). In addition to identifying DNaseI-hypersensitive (DHS) regions that may 
act as putative CRMs, deep sequencing allows sufficient resolution to identify 
shorter sequences within DHS protected from DNaseI cleavage. These protected 
regions or footprints represent putative TF binding sites. These DHS and footprint 
regions can be computationally analyzed to discover novel regulatory motifs. While 
a previous study looked at DNaseI hypersensitivity in C. elegans young adults by 
hybridizing to DNA tiling arrays and was able to identify 7095 large DNaseI 
hypersensitive regions that ranged from 46 bp to 754 bp long, the data did not give 
sufficient resolution to identify TF footprints and it was not clear whether the 
authors had indeed located known CRMs (Shi et al. 2009). 
In this study we describe the mapping of cis-regulatory protein-DNA 
binding within the C. elegans genome in embryos and L1 arrest larvae using deep 
sequencing of DNA extracted from DNaseI-treated chromatin. Our studies identify 
41,825 and 23,674 reproducible DHS peaks in embryos and L1 arrest larvae, 
respectively, using samples that on average comprise 30 million Illumina HiSeq 
50-76bp single reads, giving 15X coverage of the 100 million base pair C. elegans 
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genome. 
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Results 
A DNase-seq method for C. elegans 
To identify DNaseI hypersensitivity sites in C. elegans, we performed 
DNaseI treatment on three and four high-quality biological replicate samples of 
embryos and L1 arrest larvae, respectively. We then isolated DNA fragments less 
than 500bp that represent chromatin regions most accessible to DNaseI cleavage 
(Figure 1.1A; see methods for details). QPCR was used to identify DNaseI 
treatment conditions that resulted in the highest enrichment of regulatory regions 
in the DNase-seq sample, using primers designed against conserved known 
enhancers from the lin-39/ceh-13 Hox cluster (Kuntz et al. 2008) and negative 
control regions lacking any known regulatory activity (see Methods). DNase-seq 
samples were sequenced to 15X coverage of the C. elegans genome and the read 
data were used to identify regions with increased hypersensitivity across 150 bp 
consecutive nucleotides using HOTSPOT DNaseI peak-calling software (John et al. 
2011) (Figure 1.1.C). Raw peak calls were filtered using the irreproducibility 
discovery rate (IDR) framework developed for ENCODE, which uses a non-
parametric copula mixture model to filter peaks into reproducible or irreproducible 
categories (Li et al. 2011). Peaks were selected on combination of rank or score and 
consistency across replicates to yield 41,825 embryonic and 23,674 L1 arrest 
DNaseI hypersensitive sites (DHS). 
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Figure 1.1 Experimental method and reproducibility 
A. Experimental Method. Wild-type N2 worms were grown synchronously for at least two 
generations. Embryos at around the 40-cell stage or L1 arrest larvae were collected and frozen at -
80C. Freeze-thaw cycles in a nuclei purification buffer and a Dounce homogenizer were used to 
isolate nuclei. Nuclei (blue) were purified by spinning on Optiprep density gradient medium and 
visualized with DAPI (see Methods). Nuclei were divided into aliquots and DNaseI treatment was 
performed at 0, 20, 40, 80, 120, 160 U/mL DNaseI concentration.  Resulting DNA was isolated by 
treatment with Proteinase K, RNaseA, column purification, and size selection by gel extraction. 
DNA was quantified using Qubit fluorescence. Enrichment in regulatory regions was verified using 
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QPCR designed against lin-39/ceh-13 Hox enhancers. The sample with highest relative fold 
enrichment for regulatory regions was selected for library construction and sequencing.  
B. Reproducibility of read coverage over DHS in embryo biological replicates. Pair-
wise comparisons of embryo biological replicate DNase signal across all identified Raw (green) and 
IDR-filtered (blue) DHS show good reproducibility. Signal is measured in log2 of reads per base 
pair. Black diagonal line represents the ideal case of perfect reproducibility. 
 
 
 
 
 
C. Computational analysis 
workflow. Italics indicate the 
software packages used (see 
Methods). 
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D. Biological replicates show reproducibility of matched peaks. Comparison between 
number of common peaks and significant peaks in pairs of biological replicates when all raw peaks 
are assessed together (All Peaks) or peaks matching in replicates (Matched Peaks). Pair-wise 
comparisons of biological replicates: A vs. B (red), B vs. C (green) and A vs. C (blue) are shown. 
E. Observed relationship between irreproducible discovery rate (IDR) threshold and 
number of significant peaks called in biological replicates. 69,155 reproducible embryo 
DHS peaks remained after IDR filtering using threshold 0.1. Filtering for ce10 blacklist regions and 
repeat regions resulted in 41,825 embryo DHS peaks (see Appendix Figure 2.5 B-C for L1 arrest 
data). 
 
Regions with high enrichment of reads in one DNase-seq replicate are 
generally observed to have high enrichment in other biological replicates from the 
same condition (Figure 1.1B shows embryo data, see Appendix Figure 2.5 B-C for 
L1 arrest data). Comparing raw peaks from HOTSPOT to DHS peaks filtered by 
IDR, we observed that filtering by IDR successfully removes peaks with low read 
coverage and some very high scoring peaks that did not pass replicate consistency 
requirements. We observe a robust correlation between numbers of significant 
peaks and common peaks at most levels of peak calling for the overlapping peaks 
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(the subset of peaks that overlap in replicates) compared to total peaks 
(Figure 1.1C). The irreproducible discovery rate (IDR) compared to the statistical 
significance of the peaks shows a shallow slope, indicating that we are able to call a 
large number of significant peaks at a low IDR (Figure 1.1D-E) (Li et al. 2011; Landt 
et al. 2012). 
After comparison with the WS241 C. elegans genome annotation, we found 
that 26,644 and 15,841 of these embryonic and L1 arrest DHS, respectively, overlap 
with noncoding regions of the genome and represent putative active CRMs in these 
conditions. To identify regions within noncoding DHS that could be footprints of 
TF binding sites, we searched for signatures of TF footprints (protection from 
DNaseI cleavage and positive-to-negative strand shift in reads) using DNase2TF, 
which has been shown to perform significantly better and recover more accurate 
peaks compared to other algorithms such as Wellington and DNaseR (Sung et al. 
2014). We were thus able to discover 55,890 and 32,685 putative DNaseI TF 
footprints within these noncoding DHS in the C. elegans embryo and L1 arrest, 
respectively. Comparing the embryo and L1 arrest datasets, we observe 1,854 
condition-specific DHS in L1 arrest harboring 2,964 TF footprints. 
DHS peaks are most abundant in noncoding regions and DNaseI 
hypersensitivity correlates with expression 
Annotation of peaks with WormBase WS241 gene models revealed that DHS 
peaks are most abundant (55%) in noncoding regions (Figure 2.2A). Less than half 
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(45%) occur within exons, which is expected as DHS were found throughout 
exons of actively transcribed genes (Mercer et al. 2013). Above half were observed 
in noncoding regions, with 23% in intergenic regions, 11% in promoters (defined as 
less than 300 bp of exon start), and 21% in introns. Noncoding DHS residing in 
introns, intergenic and promoter regions, by being accessible to DNaseI, may thus 
represent candidate CRMs.  Similar statistics were observed in L1 arrest larvae 
with 67% of DHS in noncoding regions of the genome; with 28% in intergenic 
regions, 13% in promoters, and 27% in introns (Appendix Figure 2.5A). 
 
Figure 2.2.A Genomic location of embryo DHS shows abundance of noncoding DHS. 
Embryo DHS were annotated according to position relative to WormBase WS241 protein-coding 
genes: exons (blue) and noncoding (red). Noncoding DHS are further subdivided into introns 
(pink), promoter (defined as less than 300bp 5’ of ATG; yellow) and intergenic (orange) regions. 
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Most genes exhibit a uniform distribution of reads over the gene body and 
surrounding sequence with an average of 20 mapped reads per bp (Figure 2.2B). 
However, about 9% of genes exhibit much higher read coverage and show a pattern 
of three peaks of read enrichment reaching as high as 120 mapped reads per bp. 
These peaks correspond to the 5’ upstream region, gene body, and 3’ downstream 
region. We observe that this subset of genes with higher and tri-modal patterns of 
read enrichment are 66% more highly expressed in embryo than genes with lower 
and uniform pattern (two-sided Kolmogorov-Smirnov (KS) test, p = 1.1x10-8) 
(Figure 2.2B). 
 
Figure 2.2.B Protein-coding genes with higher DNase accessibility are more highly 
expressed. Read coverage (total DNaseI signal across biological replicates) was measured for 
length-normalized WormBase WS241 protein-coding genes and 1kb of surrounding sequence. k-
means clustering of genes by read coverage was used to find genes with higher (High) and lower 
read coverage (Low). Embryo expression (from Zhong et al. 2010) which is measured in log2 of 
fragments per kilobase of exon per million fragments mapped (FPKM) was compared between 
higher read coverage (H) vs. lower (L) read coverage genes. 
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Noncoding DHS are twice as conserved as expected by random chance 
and DNaseI hypersensitivity is strongly correlated with sequence 
conservation 
Comparing median DNaseI hypersensitivity and sequence conservation in a 
2kb region surrounding noncoding DHS, we find that levels of DNaseI 
hypersensitivity strongly correlate with sequence conservation on a per nucleotide 
basis (Figure 2.2C). Both DNaseI hypersensitivity and sequence conservation peak 
at the midpoint of noncoding DHS and are centered in a 400bp region surrounding 
the site. If we compare with levels of sequence conservation of known enhancer 
CRMs such as those in the lin-39/ceh-13 Hox complex we find that median phyloP 
sequence conservation was 0.543 for true positive enhancers in Kuntz et al. (2008), 
suggesting a typical size for CRMs of C. elegans of about 200bp. True negatives in 
the same study showed phyloP sequencing conservation of about 0.43 (see 
Methods for details). A typical size noncoding DHS of 150bp thus captures the bulk 
of both the DNaseI hypersensitivity and sequence conservation. DHS peaks in 
noncoding regions are on average twice as conserved on a per nucleotide basis than 
expected by chance (two-sided KS test, p < 3 x 10-16). 
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Figure 2.2C. DNase accessibility and phyloP sequence conservation both reach a peak 
in embryo noncoding DHS. Median DNase signal (green; measured in 5bp windows) and 
phyloP score (pink; 7 way) are measured across 2kb of sequence surrounding embryo noncoding 
DHS, and peak in the embryo noncoding DHS at 70.5 reads in a 5 bp window and at 0.66 for 
phyloP sequence conservation. The level of phyloP conservation for known true positive lin-
39/ceh-13 enhancers is 0.54 (blue) and for negative control non-enhancer regions is 0.43 (orange 
line; see Methods). 
 
Noncoding DHS are highly enriched in marks of enhancer activity and 
transcription 
Embryo DHS peaks are significantly enriched in embryonic sites of 
transcription initiation (TSS) (4.2 fold, two-sided KS test, p < 3 x 10-16) (Chen et al. 
2013) and overlap many annotated noncoding RNAs. The average DNase profile of 
these TSS shows enrichment of read coverage in the surrounding 400bp sequence, 
demonstrating high accessibility to DNaseI cleavage, with even higher accessibility 
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within the noncoding DHS themselves (Figure 2.2D). Comparison with data 
from a different study using GRO-cap sequencing to identify C. elegans TSS also 
showed that embryo and L1 arrest larvae are 7.9 and 7.7-fold enriched, 
respectively, in stage-matched sites of transcription identified by this study (Kruesi 
et al. 2013) (two-sided KS tests, p < 3 x 10-16). 
 
Figure 2.2D Median DNase signal peaks in C. elegans transcription start sites and 
shows 5’ bias. Median DNase signal (measured in 5bp windows) is measured in 2 kb of sequence 
surrounding embryo transcription start sites (TSS) (locations from Chen et al. 2013), with the 
orientation placed according to the direction of transcription (5’ to 3’ is shown from left to right) 
and the center of the TSS indicated at 0 bp (gray dotted line). DNase signal peaks at All TSS (red) 
and at TSS within noncoding DHS (purple) and shows strongest DNase accessibility just 5’ to the 
TSS. 
 
Comparing embryonic noncoding DHS to stage-matched H3K4me3 
ChIP-seq and C. elegans p300 homolog CBP-1 ChIP-chip peaks from 
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modENCODE, they are significantly enriched in marks associated with potential 
enhancer regulatory activity in eukaryotic genomes (2.8 fold, p < 3 x 10-16) 
(Heintzman et al. 2007). Also, 199 (65%) of 304 high occupancy target (HOT) 
genomic core regions bound by fifteen or more TFs tested by modENCODE overlap 
with embryo DHS (5.1 fold, p < 3 x 10-16; Gerstein et al. 2010).  57% of RNA 
polymerase II binding regions identified in early embryos by modENCODE overlap 
our observed embryo DHS (1.38 fold, p < 3 x 10-16) (Gerstein et al. 2010). 
 
Figure. 2.3A Half of embryo noncoding DHS coincide with transcription start sites 
(TSS), histone marks, CBP-1, and HOT regions. 47% of noncoding DHS with marks of 
enhancer activity such as RNA Polymerase II (RNA Pol II; yellow), transcription start site (TSS; 
blue), CBP-1 (pink), H3K4me3 (green) observed in embryos and modENCODE high occupancy 
transcription factor regions (HOT; orange). TSS data are from Chen et al. (2013) and remaining 
data are from modENCODE (Gerstein et al. 2010). 
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Nearly half (46%, 12,160) of noncoding DHS overlap with one or more 
marks of transcription (initiation sites, CBP-1 transcriptional co-activator, RNA 
polymerase II, H3K4me3 histone marks) or high TF occupancy (modENCODE 
HOT regions) from stage-matched samples (Figure 2.3A). 14,484 (54%) noncoding 
DHS do not overlap with any such marks. Of noncoding DHS that do overlap with 
these marks, most (57%, 6,956) overlap with just one mark, while 3,424 overlap 
with two marks, 1,373 overlap with three marks,  375 overlap with four marks, and 
32 overlap with five marks. Genes associated with noncoding DHS possessing one 
or more marks are on average 8.9-fold more highly expressed in embryos 
compared to genes with noncoding DHS lacking any marks (p < 2.2x10-16 
two-sided KS test) (Figure 2.3B).  Moreover, genes associated with embryo 
noncoding DHS overlapping with greater numbers of marks correlates with 
increased embryonic expression, up to three marks (5.1-fold higher expression 
compared to one mark, p < 3 x 10-14). 
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Presence of at least one noncoding DHS peaks is correlated with gene 
expression  
10,890 (53%) protein-coding genes were assigned at least one DHS nearby 
according to our annotation that assigned the nearest gene to each DHS (Appendix 
Figure 2.3B). 9,822 (47%) protein-coding genes did not possess nearby noncoding 
DHS.  The presence of at least one embryo noncoding DHS near a gene is 
 
Figure 2.3.B Genes associated with any noncoding DHS harboring enhancer-
associated marks are 9-fold more highly expressed than those with DHS lacking any 
marks. Genes near embryo noncoding DHS with any number of marks (at least one, two, three, 
four, or five type(s) of enhancer-associated mark) exhibit, on average, 8.9-fold higher levels of 
embryo expression (measured in log2 of FPKM, data from Zhong et al. 2010) compared to those 
with embryo noncoding DHS lacking marks (p < 3 x 10-16 , two sided KS test). With each additional 
mark, median observed expression increases, up to three marks (5.1-fold higher expression 
compared to one mark, p < 3 x 10-14). No significant difference is observed between genes near 
noncoding DHS with three, four or five marks. 
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associated with 4.5-fold higher embryo expression compared to genes lacking 
DHS (p < 3 x 10-16, two-sided KS test; Figure 2.3C). There is 54% increase in 
embryo expression between one and two noncoding DHS near a gene and 44% 
increase from two to three (two-sided KS tests, p < 3x10-6 and p < 0.007, 
respectively). Additional increases in noncoding DHS beyond three DHS per gene 
do not increase expression. Genes with DHS that do not have any marks are still 
2.3-fold more expressed compared to genes lacking any DHS (p < 3 x 10-16, 
two-sided KS test) (Figure 2.3D). 
 
Figure 2.3.C The presence of at least one embryo noncoding DHS near a gene is 
correlated with 4.5-fold higher embryo expression. Comparison of embryo expression 
between genes with zero and one to ten noncoding DHS peaks shows that the presence of at least 
one embryo noncoding DHS is associated with 4.5 fold higher embryo expression compared to 
none (p<3x10-16).  Embryo expression, measured as log2 of the fragments per kilobase of exon per 
million reads mapped (FPKM; data from Zhong et al. 2010) increases 54% from one to two embryo 
noncoding DHS (p < 3x10-6) and 44% from two to three (p < 0.007). However further increases in 
DHS are not correlated with expression. 
 
  
59
 
 
 
Figure 2.3.D. Genes associated with embryo noncoding DHS 
and lacking marks are still twice as highly expressed as genes 
without DHS. Genes with embryo noncoding DHS lacking enhancer-
associated marks (orange) show 2.3-fold higher embryo expression 
compared to genes lacking DHS (blue; p < 3 x 10-16). 
 
 
Within noncoding embryo DHS peaks, we identified 55,890 potential TF 
binding sites (TFBS) using DNase2TF (Sung et al., 2014). Regions between 6-40 bp 
within noncoding DHS that showed less coverage than neighboring nucleotides 
and exhibited a strand shift in mapped reads characteristic of TF binding were 
identified as potential TF footprints using an FDR cutoff of 0.05. Most (21857, 
82%) of noncoding DHS possess detectable footprints, whereas 18% (4787) do not 
(Appendix Figure 2.3A). This pattern largely holds true even when we subdivide 
noncoding DHS according to overlap by marks (TSS, H3K4me3, RNAPII, CBP-1 
and HOT) (Appendix Figure 2.3A). We did not detect any difference in expression 
between genes associated with DHS that do have detectable footprints and those 
that do not. These data fit the model that DHS peaks represent potential CRMs, 
with many of the hallmarks of CRM activity including sequence conservation, 
active transcription, H3K4me3, and TF occupancy.  
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Embryo noncoding DHS peaks and footprints coincide with many 
known CRMs 
To investigate whether the locations of previously investigated enhancers 
can be identified by our DNase-seq method, we examined several C. elegans 
genetic loci harboring known enhancers, particularly those of the lin-39/ceh-13 
Hox locus and genes active in embryos. The genetic locus containing Hox 
anterior-posterior patterning genes ceh-13 and lin-39 and lincRNA linc-57 is 
known to harbor numerous enhancers that are as far away as 20 kb from target 
genes. A previous study identified enhancers using MUSSA (multi-species 
sequence analysis using ungapped transitive alignments) to find conserved 
sequences across several Caenorhabditis species and characterized their 
expression patterns in transgenic reporter assays (Kuntz et al. 2008). Within these 
large enhancer regions, ranging from 591 bp to 1120 bp, they also identified smaller 
15-33 bp MUSSA conserved sub-regions. 
We observed several noncoding DHS in our embryo data that overlap these 
previously identified lin-39/ceh-13 enhancers (Figure 2.4 A, B; Appendix Figure 
2.1A). Specifically, observed noncoding DHS peaks pinpointed core MUSSA 
conserved regions of seven (N1, N2, N3, N4, N8, N10, and N11 enhancers) of the 
nine enhancers previously identified. We also observed noncoding DHS within two 
“false negative” regions (I4 and I8) able to drive expression in the Kuntz et al. 
study (2008). Regarding potential false positives, we found one noncoding DHS in 
N5 that does not appear to drive reporter expression (Figure 2.4B). We also 
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observe TF footprints within several noncoding DHS.  Footprints were detected 
within noncoding DHS peaks corresponding to six (N1, N2, N3, N8, N10 and N11) 
of the nine enhancers (Appendix Figure 2.1A). We also find footprints in noncoding 
DHS found within the I4 and I8 enhancers reported as a “false negative” by Kuntz 
et al. (2008; Figure 2.4B) Surprisingly, while some of these enhancers do not 
apparently drive reporter expression until later in development, our data raise the 
possibility that the chromatin surrounding these regions is already accessible to 
DNaseI in the early embryo. These examples include N1, which drives expression 
in L4 through adulthood, but which we observe to be hypersensitive in embryos 
(Kuntz et al. 2008) (Figure 2.4A).  
Figure 2.4 Noncoding DHS coincide with known CRMs  
Total DNaseI signal (red) from both strands of embryo read data shown, as well as individual 
DNaseI signal from positive (orange) and negative (green) strands. Noncoding DHS (light blue 
boxes) and all DHS (medium blue boxes) and TF footprints (dark blue boxes) detected. Additional 
tracks are C. elegans RefSeq genes (black boxes with arrows), noncoding transcripts (brown 
boxes), and phyloP conservation (very dark blue).  Other tracks (if shown) include TSS (dark 
orange boxes; Chen et al. 2013), RNAP II ChIP-seq (red boxes), H3K4me3 (pink) and CBP-1 
(lavender boxes), ChIP-chip and HOT regions (yellow boxes) from modENCODE embryo data. 
MULTIZ conserved elements (magenta boxes) and Repeatmasker elements (black boxes) are also 
shown. 
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We then examined well-studied gene loci representing major tissue 
regulators or structural genes expressed during embryonic development. The 
epithelial differentiation factor lin-26 begins to be expressed in early embryos in all 
epithelial cells of the ectoderm and is responsible for somatic gonad differentiation 
(Landmann et al. 2004). elt-2 is an intestinal terminal differentiation TF (McGhee 
et al. 2009) whose expression first appears in mid 2E-cell stage (Fukushige et al. 
1998). myo-3 is a myosin heavy chain gene that begins expression during the 
pre-comma stage and is eventually expressed in all muscle cells outside of the 
pharynx (Fox et al. 2007; Okkema et al. 1993). myo-2 is a myosin heavy chain gene 
whose expression begins later in the 2-fold stage embryo and is expressed in all 
pharyngeal muscle cells (Okkema and Fire 1994; Gaudet and Mango 2002). These 
embryonic expression patterns led us to expect that some of their CRMs would 
exhibit DNaseI hypersensitivity in embryos. 
A previous study identified sequences required for proper expression of 
lin-26 upstream of the gene in an 11kb region spanning the first intron of lir-1 
(Landmann et al. 2004).  We are able to detect at least one noncoding DHS and 
multiple footprints in each of the five previously described enhancer regions 
corresponding to the A+B (Late), C+D (Late), E (Intermediate), F+G 
(Intermediate) and H (Early) enhancers. Of these enhancers, A+B (Late) and C+D 
(Late) are bound and regulated by PHA-4. The noncoding DHS and footprints we 
detect in these two enhancers correspond to the locations of PHA-4 ChIP-seq peaks 
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previously observed in embryos (Zhong et al. 2010) (Figure 2.4C). 
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The promoter and 5’ upstream region of elt-2 shows several DHS that 
coincide with elt-2 ChIP-seq peak data (E. Osborne Nishimura and J. McGhee, 
personal communication). Studies have shown that elt-2 is auto-regulated by 
binding to its own promoter in embryos (Fukushige et al. 1999). In addition, two 
TF footprints are detected within the distal enhancer and promoter of elt-2 (Figure 
2.4D). 
Regulation of myo-2 expression by its A, B, and C sub-elements has been 
extensively dissected (Okkema and Fire 1994).  We observe one noncoding DHS 
and associated footprint that overlap with the minimal myo-2 promoter bound by 
PHA-4 in embryos, corresponding to a pan-pharyngeal element (Kalb et al. 1998). 
Another noncoding DHS detected in our study overlaps with the B and C sub-
elements that drive pharyngeal expression in reporter assays (Figure 2.4E). In 
particular, we detect a putative TF footprint in the sub-element C which binds 
PHA-4 (Kalb et al. 1998; Okkema and Fire 1994) through genetic evidence and 
PHA-4 ChIP-seq data (Zhong et al. 2010).  Noncoding DHS peaks are observed in 
both the first intron and upstream region of myo-3, coinciding with three 
enhancers MC186, MC197, and MC165 previously reported to drive reporter 
expression (Okkema et al. 1993). Noncoding DHS that coincide with these 
enhancers possess several TF footprints (Appendix Figure 2.1B). 
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Embryo noncoding DHS partially recapitulate enhancers defined in 
another C. elegans locus encoding hlh-1, a major bHLH TF of body wall muscle 
(BWM) that begins expression in embryos (Krause et al. 1994; Lei et al. 2009). The 
noncoding DHS and TF footprints that we observe at this locus overlap with the 
enh1 region and enh2 regulatory regions reported to drive expression in BWM 
precursors D+C and MS+D+C, respectively (Appendix Figure 2.1C). However, the 
specific P1 and E1 regions that bind PAL-1 and HLH-1, respectively, within enh1 
and the enh3 regions are closely located to but do not overlap with our identified 
noncoding DHS. This discrepancy may be partly due to weak and broad DNaseI 
signal at the locations, which were not called by our peak calling method as part of 
the DHS.  Our data also do not detect the enh4 enhancer.  
To investigate whether the noncoding DHS we observe in the C. elegans 
embryo may represent not only enhancers but also potential repressors or sites of 
negative regulation, we examined the intergenic region between col-43 dauer 
collagen and sth-1, which is expressed in spermatheca. Two homeodomain proteins 
MAB-18 (also known as VAB-3) and CEH-14 are required to insulate col-43 from 
activation by the adjacent promoter of sth-1 (Bando et al. 2005) and are anteriorly 
expressed in the early embryo (Chisholm and Horvitz 1995; Kagoshima et al. 
2013). Homeodomain binding sites HB1 and HB2 for MAB-18 and CEH-14 or 
MAB-18 alone, respectively, reside in the intergenic region. We observed one 
embryo noncoding DHS with a TF footprint overlapping the HB1 site that is part of 
the spermathecal enhancer (Bando et al. 2005). Another noncoding DHS 
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harboring a TF footprint overlaps the HB2 site and an embryo TSS (Chen et al. 
2013) (Appendix Figure 2.1D).  
DNase-seq data predict additional novel enhancers and distant-acting 
CRMs 
Even within the well-studied gene loci we investigated, we detected several 
novel regulatory elements. Some of these predictions include noncoding DHS in 
the first intron of and downstream of ceh-13, which were not tested in the Kuntz et 
al. (2008) study, but are conserved and transcribed and which may represent 
additional ceh-13 regulatory elements (Appendix Figure 2.1A). Another example is 
that of footprints and noncoding DHS observed in the 6th and 10th introns of 
myo-2 that overlap with other PHA-4 ChIP binding sites. Since PHA-4 is a 
transcriptional regulator of pharynx expression, these noncoding DHS may 
represent additional PHA-4 regulated enhancers of myo-2 (Figure 2.4E). In 
addition, we observe a noncoding DHS in the 1st intron of hlh-1 corresponding to a 
region that is bound by PHA-4 in embryos (Zhong et al. 2010). We expect that 
hlh-1 is repressed by PHA-4 in the pharynx through this putative CRM. 
 Our data also provide additional evidence for distant-acting regulatory elements 
in C. elegans. Nearly half (6,312) of the noncoding DHS detected in the C. elegans 
embryo are situated less than 500bp to the nearest gene (Figure 2.5A). However, 
4,724 (43%) are between 500bp and 2kb from the nearest gene and 3,895 (26%) 
are over 2kb away, up to 11kb away. 
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Figure 2.5A Distance of intergenic and promoter DHS to nearest protein-coding 
gene shows additional evidence for relatively distant CRMs. A little over half (56%; 8,418) 
of intergenic and promoter DHS are found within 1kb of the nearest protein-coding gene, and most 
(74%; 11,036) are within 2kb. However, a minority (26%, 3,895) of intergenic and promoter DHS 
are greater than 2kb away and 10% (1,480) are more than 4kb away. 
 
Discriminative motif discovery within noncoding DHS peaks recovers 
many known promoter and TF regulatory motifs 
We performed discriminative motif discovery to identify overrepresented 
motifs within noncoding DHS peaks and putative TF footprints using DREME 
(Bailey et al. 2011). We surmised that overrepresented motifs within these 
noncoding peaks and footprints might represent sites of TF binding and regulatory 
activity. Many known C. elegans regulatory motifs matched overrepresented motifs 
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found in noncoding DHS, including SL1, Kozak and T-blocks regulatory motifs 
that were previously described in C. elegans core promoters (Grishkevich et al. 
2011). We also detect DNA binding motifs of pharyngeal TF PHA-4 expressed in 
embryos (Figure 2.5B) (Gaudet et al. 2004; Zhong et al. 2010). In addition, we find 
DNA binding motifs for embryonic regulators EFL-1 (Page et al. 2001), GEI-11 
(Tsuboi et al. 2002), EGL-27 (Solari et al. 1999), which regulate embryonic 
asymmetry, ventral enclosure, and embryonic patterning respectively, and the 
motif for neuronal nuclear receptor UNC-55 (Zhou and Walthall, 1998). 
Among motifs situated in the promoter (<300 bp upstream of ATG start), 
intergenic, and intron DHS, we detected additional C. elegans motifs.  In promoter 
DHS we recover C. elegans TATA-box and SP1 canonical promoter motifs 
(Grishkevich et al. 2011), as well as binding motifs for ELT-2 intestinal TF (McGhee 
et al. 2009), and CEH-28, a NK-2 homeodomain TF expressed in the M4 neuron 
and other extra-pharyngeal neurons in embryos (Ray et al. 2008). In intergenic 
DHS, we find the intestinal TF SLR-2 (Kirienko and Fay 2010), the N1 
pan-neuronal regulatory motif (Ruvinsky et al. 2007), and motifs of EGL-5, a TF 
expressed in the posterior half of the embryo (Ferreira et al. 1999; Baum et al. 
1999), and NHR-6, a nuclear hormone receptor with several roles in development 
including embryo morphology (Gissendanner et al. 2008). 
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Figure 2.5B. Known motifs recovered from noncoding DHS regions 
Unless otherwise specified, comparison motifs are from modENCODE (Gerstein et al. 2010; Araya 
et al. 2014). 
Noncoding peak motifs. Motifs match many C. elegans regulatory motifs, including promoter 
T-blocks (Grishkevich et al. 2011), and TF binding motifs of PHA-4 (Gaudet et al. 2004), EFL-1, 
UNC-55, GEI-11, and EGL-27. 
Promoter peak motifs. Motifs match SP1 and TATA-box core promoter motifs (Grishkevich et 
al. 2011), and TF binding motifs of ELT-2 (McGhee et al. 2009), and CEH-28. 
  
75
 
Intergenic peak motifs. Motifs match the Kozak motif (Grishkevich et al. 2011), and TF binding 
motifs of SLR-2 (Kirienko and Fay 2010), N1 pan-neuronal motif (Ruvinsky et al. 2007), EGL-5, 
and NHR-6. 
Intron peak motifs. Motifs match several regulatory motifs, including SL1 core promoter motif 
and Kozak sequences (Grishkevich et al. 2011), and EGL-5 TF binding motif. 
 
From noncoding DHS associated with gut-specific genes we recovered DNA 
motifs resembling binding motifs of known intestinal differentiation factors ELT-2 
and SLR-2 (McGhee et al. 2009; Kirienko et al. 2008; Kirienko and Fay 2010) 
(Appendix Figure 2.3C). In the noncoding DHS associated with neuronal-specific 
genes we found the TF binding motif for EGL-5 which is involved in development 
of the posterior nervous system (Ferreira et al. 1999; Baum et al. 1999) (Appendix 
Figure 2.3D). 
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Nucleotide-level DNaseI cleavage accessibility across C. elegans cis-
regulatory motifs  
 We measured the pattern of DNaseI cleavage accessibility across predicted 
cis-regulatory DNA motifs on a nucleotide level. We focused our attention on 
known motifs recovered in our study (Figure 2.5B). When we mapped average 
DNaseI cleavage in a window surrounding motif sites identified within 2kb 
upstream regions of protein-coding genes, almost all the motifs showed patterns 
characteristic of TF footprints, with a lower read coverage centering around the 
DNA motif indicating protection from DNaseI cleavage and a symmetric shift 
between reads aligning to positive and negative strands of the genome (Figure 
2.6A; Appendix Figure 2.4).  
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Figure 2.6A. Average DNase profile over C. elegans motif sites. C. elegans motif sites 
show characteristic patterns of DNaseI cleavage accessibility and demonstrate strand-shift in reads 
that is indicative of TF footprints. Average DNase profile is calculated over thousands of predicted 
motif sites within 2 kb upstream region of genes using start sites of reads across 80bp region 
surrounding motifs. Positive (red) and negative strand (green). Light blue shading shows base pair 
position of motif: ELT-2 (10bp motif), EFL-1 (10bp), SLR-2 (13bp), CEH-28 (8bp), GEI-11 (16bp 
motif), and NHR-6 motif 1 (7bp). 
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Prediction of novel cis-regulatory motifs 
We also found many other novel motifs overrepresented in noncoding DHS 
for which there were no known functions. Some of these matched conserved DNA 
motifs found by two prior studies in C. elegans and other nematodes using 
alignment-based approaches (Ihuegbu et al. 2012) and gene orthologs (Elemento 
and Tavazoie 2005). We performed Gene Ontology and anatomy enrichment 
analysis on genes associated with these noncoding motifs in order to predict 
function (Table 2.1; Appendix Table 2.3). A variety of GO annotations of biological 
function were enriched, including response to stimulus (e.g. AAAATTCMAAA 
enriched in head neurons; MAACAACAACAA enriched in ventral cord neurons) 
and hormone signaling (e.g. ACTACAAACTAC enriched in excretory cell). 
Regulation of localization was enriched in several motif associated genes 
(CGCGCAAATGA; GCRGCCGACA enriched in intestine and muscle including 
vulval and body wall). Selected motifs are outlined in Table 2.1, with additional 
motifs in Appendix Table 2.3. 
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Table 2.1. Selected novel predicted regulatory motifs 
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Selected novel predicted regulatory motifs and gene ontology analysis of motif-associated genes. 
Left border shows category of noncoding DHS where motif is overrepresented. p-values (p-val) and 
erased E-value (E-val) of each of the identified motifs are shown, along with whether motif matches 
previously identified Stormo or Elemento motifs (Ihuegbu et al. 2012; Elemento et al. 2005), and 
FIMO threshold (Threshold) used to select motif-associated genes. Number of motif-associated 
genes (#Genes) used in GO enrichment analysis. Gene names of some motif-associated genes 
(Example Genes) are shown. Both IUPAC motif and motif logos are shown.  Blue background 
indicates related GO terms. Top enriched GO terms are shown (see methods). Enriched anatomy 
terms, if present, are shown in square brackets. 
 
DNase-seq data refines prediction of tissue-specific genes by regulatory 
DNA motifs 
We investigated whether DNase-seq data would be able to improve our 
ability to predict the tissue-specific expression of genes regulated by known DNA 
motifs. The N1 pan-neuronal regulatory motif predicts genes expressed widely in 
neuronal cells (Ruvinsky et al. 2007). Similarly, the ELT-2 motif is found near 
intestinally expressed genes (McGhee et al. 2007). Other important TFs with 
known roles in the intestine include C. elegans homolog of Homothorax/Meis 
UNC-62 (Van Nostrand et al. 2013; McGhee et al. 2007; Van Auken et al. 2002) 
and SLR-2 (Kirienko et al. 2008; Kirienko and Fay 2010). We compared the 
percentage of genes correctly predicted to be expressed in neuronal or intestinal 
tissues using the presence of predicted DNA motifs alone versus the presence of 
DNA motifs within noncoding DHS (see Methods). In both cases we were able to 
improve prediction accuracy using noncoding DHS together with motifs, from 41% 
to 55% of genes in FACS-sorted neuronal tiling array (McGhee et al. 2009) and  
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Figure 2.6B. Using 
regulatory motifs found 
within noncoding DHS to 
refine prediction of tissue 
specific gene expression. 
The percentage of genes 
correctly predicted to be 
expressed in the tissue 
expression dataset from the 
presence of DNA regulatory 
motif (Motif Only) was 
compared to presence of DNA 
regulatory motif within 
noncoding DHS (Motif + 
Noncoding DHS). Taking into 
account the presence of N1 
motifs within noncoding DHS 
improves prediction accuracy of 
neuronal expression from 41% 
to 55% (data from McGhee et al. 
2009; purple). Taking into 
account gut regulatory TF ELT-
2 (blue), SLR-2 (green) and 
UNC-62 (brown) motifs located 
specifically within noncoding 
DHS improves prediction 
accuracy of embryonic 
intestinal expression (FACS 
data from Spencer et al. 2011) from 8%, 4% and, 5%, respectively  to 28%, 25%, and 20%, 
respectively. Taking into account ELT-2 (red), SLR-2 (orange) and UNC-62 (pink) motifs within 
noncoding DHS slightly improves prediction accuracy of expression in adult dissected intestines 
(data from McGhee et al. 2007) from 29%, 27%, and 25%, respectively to 36%, 32%, and 28%, 
respectively. 
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from 8%, 4%, 5%, respectively using ELT-2, SLR-2, and UNC-62 motif only to 
28%, 25%, 23%, respectively of genes in FACS embryonic intestine using ELT-2, 
SLR-2, and UNC-62 motifs within noncoding DHS (Figure 2.6B) (data from 
Spencer et al. 2011). We also show smaller improvement from 29% (ELT-2), 27% 
(SLR-2), and 26% (UNC-62) to 36%, 32%, 31%, respectively in adult dissected gut 
(data from McGhee et al. 2007). The result of these analyses using DNase-seq data 
is a smaller but more accurately predicted set of genes expressed in neurons or 
intestine. 
Most L1 arrest regulatory elements discovered by DNase-seq are also 
found in the embryo, whereas 12% appear to be L1 arrest condition-
specific and reflect higher gene expression 
Comparing DNase-seq data between L1 arrest and embryo conditions, we find 
that most (88%) of the 16,084 noncoding DHS found during the L1 arrest stage were 
also found in the embryo. However 1,854 (12%) appear to be specific to the L1 arrest 
condition, when compared to C. elegans embryo DNase-seq data. We are also able to 
identify 9,359 putative transcription factor footprints in L1, with 2,946 TF footprints 
residing in L1 condition-specific elements. Genes with L1 condition-specific 
regulatory elements have 12.5% higher expression in the 6hr L1 starved larvae 
compared to the embryo (Appendix Figure 2.5E, expression data from Baugh et al. 
2009, two-sided KS test, p < 1.6 x 10-8).  
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L1 arrest condition-specific noncoding DHS are found in many genes 
upregulated in L1 arrest larvae  
Of the 1,854 L1 arrest condition-specific regulatory elements, 44% (817) are 
associated with at least one category of genes we expect to be involved in the 
regulation of L1 arrest: those targeted by DAF-16 and/or PHA-4, genes responsive to 
starvation in the L1, and genes highly upregulated in L1 starved vs. embryo 
(Appendix Figure 2.5D; see Methods for defining these genes). 14% (256) of these 
genes with L1 condition-specific DHS are top DAF-16 targets (Tepper et al. 2013), 
22% are PHA-4 targets (Zhong et al. 2010), 18% are genes most responsive to 
starvation in L1 larvae (Baugh et al. 2009) and 17% are genes highly upregulated in 
L1 arrest larvae compared to embryos (Baugh et al. 2009). Furthermore, all DHS 
and noncoding DHS from L1 arrest larvae are 1.7-fold and 2.4-fold enriched, 
respectively, in PHA-4 ChIP binding sites from stage-matched samples of starved L1 
larvae (two-sided KS test, p < 3 x 10-16), suggesting that we are able to recapitulate 
CRMs for targets of PHA-4, a TF regulator of L1 starvation survival.  
We are able to detect L1 arrest condition-specific DHS in targets of DAF-16 
and PHA-4 regulated genes and other genes differentially regulated in L1 arrest by 
investigating individual gene loci. For example, icl-1 (also known as gei-7) is a key 
enzyme of the glyoxylate cycle, is involved in the breakdown of fats into 
carbohydrates, and is a known target of DAF-16 (Murphy et al. 2003; Tepper et al., 
2013). Expression of icl-1 is highly upregulated in daf-2 mutants (Murphy et al. 
2003) and in response to starvation (7.9 fold; Baugh et al. 2009; Van Gilst et al. 
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2005) and in L1 arrest compared to embryos (1.9 fold; Baugh et al., 2009). It also 
appears to be regulated by PHA-4 during embryo and L1 arrest according to ChIP 
data (Zhong et al., 2010). We detect one L1 condition-specific noncoding DHS 
harboring TF footprints which overlap both a DAF-16 binding motif (p < 1x10-4) and 
PHA-4 motif (p < 5x10-5) in the first intron of icl-1 (Figure 2.7A). Three other L1 
arrest noncoding DHS were found near icl-1 coinciding with PHA-4 ChIP binding 
peaks detected in L1 starved larvae (Zhong et al., 2010). 
Figure 2.7. L1 arrest condition-specific noncoding DHS detected in genes upregulated during 
L1 arrest. Total DNaseI signal (red) from both strands of L1 arrest DNase-seq read data shown, as well as 
individual DNaseI signal from positive (orange) and negative (green) strands.  Total DNase signal (light blue) 
from both strands of embryo DNase-seq read data is also shown. L1 arrest noncoding DHS (red) and 
associated TF footprints (pink), as well as embryo noncoding DHS (light blue boxes) and associated TF 
footprints (dark blue boxes) were detected. Additional tracks are C. elegans RefSeq genes (black boxes with 
arrows), noncoding transcripts (brown boxes), 12hr Starved L1 mRNA-seq tracks (black) from Maxwell et al. 
(2012), and phyloP conservation (dark blue) are also shown. Other tracks include PHA-4 ChIP-seq binding 
peaks from embryo (light green) and starved L1 larvae (signal shown in purple; peaks shown as purple boxes; 
Zhong et al. 2010). PHA-4, DAF-16, DAF-19 binding motifs (if relevant) are shown in purple, orange or 
magenta boxes, respectively. TSS previously found by L1 Starved GRO-cap sequencing (if relevant; data from 
Kruesi et al. 2013) is shown as dark green boxes. 
  
85
F
ig
u
re
 2
.7
A
. N
on
co
d
in
g 
D
H
S 
of
 i
cl
-1
/g
ei
-7
, w
h
ic
h
 i
s 
re
gu
la
te
d
 b
y 
bo
th
 D
A
F
-1
6 
an
d
 P
H
A
-4
. T
he
 ic
l-1
 g
en
e 
ha
rb
or
s 
on
e 
L1
 c
on
di
tio
n-
sp
ec
ifi
c 
no
nc
od
in
g 
D
H
S 
in
 th
e 
fir
st
 in
tr
on
 w
ith
 a
 D
A
F-
16
 b
in
di
ng
 m
ot
if 
(p
 <
 1
 x
 1
0-
4  t
hr
es
ho
ld
) 
an
d 
a 
PH
A
-4
 m
ot
if 
(p
 <
 5
 x
 1
0-
5 )
. T
Fs
 fo
ot
pr
in
ts
 a
re
 
de
te
ct
ed
 w
ith
in
 th
is
 n
on
co
di
ng
 D
H
S 
an
d 
ov
er
la
p 
th
e 
D
A
F-
16
 b
in
di
ng
 m
ot
if.
 T
hr
ee
 o
th
er
 n
on
co
di
ng
 D
H
S 
ar
e 
de
te
ct
ed
 in
 b
ot
h 
L1
 a
nd
 e
m
br
yo
 w
hi
ch
 
co
in
ci
de
 w
ith
 P
H
A
-4
 C
hI
P-
se
q 
bi
nd
in
g 
de
te
ct
ed
 i
n 
L1
 s
ta
rv
ed
 l
ar
va
e 
(Z
ho
ng
 e
t 
al
., 
20
10
) 
an
d 
tw
o 
of
 t
he
m
 h
ar
bo
r 
TF
 m
ot
ifs
. 
Tw
o 
ad
di
tio
na
l 
up
st
re
am
 r
eg
io
ns
 b
ou
nd
 b
y 
PH
A
-4
 in
 L
1 
st
ar
ve
d 
la
rv
ae
 w
er
e 
no
t d
et
ec
te
d.
 
  
86
 
Another example is pha-4, a TF which plays a role in L1 starvation survival 
and autoregulates its own promoter (Zhong et al., 2010). We detected multiple L1 
noncoding DHS upstream of pha-4 coinciding with PHA-4 ChIP binding regions 
during L1 arrest (Figure 2.7C). One of these DHS coincides with the TSS of pha-4c, 
the shortest isoform, which was observed in a previous study using GRO-cap in both 
embryo and starved L1 larvae (Maxwell et al. 2014). Another TSS far upstream of the 
longest isoform pha-4a was previously observed in embryos but only weakly in the 
L1 starved larvae (Maxwell et al., 2014) and coincides with a noncoding DHS in our 
embryo DNase-seq data but not in L1 arrest.  We also detect a L1 condition-specific 
noncoding DHS directly upstream of pha-4a containing multiple TF footprints. 
While this DHS harbors some PHA-4 binding motifs, it is unclear whether this 
noncoding DHS reflects PHA-4 binding (which appears to weakly bind this region) 
or binding of another TF. 
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An example of a gene whose role in L1 arrest is less well understood, but in 
which we found evidence supporting differential regulation, is the nuclear hormone 
receptor nhr-4. It is expressed in ciliated sensory amphid neurons and is directly 
regulated by RFX/DAF-19 TF (Burghoon et al 2012). Expression of nhr-4 is 
upregulated 2.3 fold in response to starvation L1 and in L1 arrest compared to 
embryos (1.5 fold; Baugh et al. 2009). We detect four L1 noncoding DHS upstream of 
nhr-4, two of which are specific to the starved L1 larvae condition (Figure 2.7C). Of 
these, one overlaps an annotated TSS previously detected by GRO-cap sequencing in 
starved L1 (Maxwell et al. 2013). The other has footprints which coincide with both a 
DAF-19 motif and a PHA-4 motif, and which appears to be weakly bound by PHA-4 
in starved L1 (Figure 2.7C; Zhong et al. 2010). The other two noncoding DHS 
detected in both the embryo and L1 arrest overlap PHA-4 ChIP peaks from both 
conditions. 
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Figure 2.7C. Noncoding DHS of nuclear hormone receptor nhr-4. Four noncoding DHS 
are detected upstream of nhr-4 in L1 arrest, all harboring TF footprints. The most proximal two are 
present only in L1 arrest and not in the embryo. The one located in the presumed promoter of 
nhr-4 overlaps an nhr-4 TSS that is detected in L1 arrest but not in the embryo by GRO-cap 
sequencing (Kruesi et al. 2013). The other overlaps both DAF-19 (p < 1x10-4) and PHA-4 (p < 5x 
10-5) TF binding motifs, which does appear to be weakly bound by PHA-4 according to ChIP-seq 
(Zhong et al. 2010). 
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Discussion 
We have identified 26,644 embryo noncoding DHS harboring 55,890 TF 
footprints and 15,841 L1 arrest noncoding CRMs harboring 32,685 TF footprints, 
through a genome-wide systematic study of cis-regulatory regions and TF binding 
in C. elegans. We are able to profile cis-regulatory sites without specifying 
particular prior TFs of interest and using chromatin accessibility as our guide. We 
have shown that we can recapitulate many known and functionally characterized 
enhancer regions and, in many cases, have refined the boundaries of the enhancer 
regions that were previously tested in transgenic reporter assays or detected 
through the relatively broad widths of ChIP-seq peaks. The DNaseI peaks 
identified here are typically only 150 bp and will be useful to define boundaries of 
many cis-regulatory modules (CRMs). We identified many known enhancers and 
TF footprints of C. elegans genes including lin-39/ceh-13, hlh-1, myo-2, myo-3, elt-
2, and lir-1/lin-26. Our data were able to recapitulate 22 of 29 known enhancers 
within these loci. In addition to correctly identifying known enhancers and TF 
footprints, our data also predict potential novel CRMs and many smaller TF 
footprints. For instance, the data predict regions downstream of ceh-13 and other 
regions that coincide with PHA-4 binding in the locus of hlh-1, where we surmise 
that PHA-4 may act to repress hlh-1 where it is expressed in the pharynx, similar to 
its role in repressing lin-26 in the pharynx. We also recovered known negative 
regulatory homeodomain sites in the col-43/sth-1 locus, suggesting that we are also 
able to find repressor CRMs. 
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It is common practice in C. elegans to regard immediate sequence 5’ of 
TSS as reflecting endogenous expression (Dupuy et al. 2007). However, there are 
numerous documented cases (reviewed in Gaudet and McGhee 2010) in which 
gene regulation is complex, being regulated from intronic, 3’, or distant 5’ 
sequences. Another study showed that while most (62%) C. elegans transcript and 
translation fusion reporter expressions replicated, expression was often observed 
in additional cells or in restricted patterns, suggesting other CRMs were involved 
(Murray et al. 2012). While we observed that most 74% (11,036) promoter and 
intergenic DHS are within 2kb of the nearest protein-coding gene, a significant 
proportion (26%; 3,895) are greater than 2kb, and 10% (1,480) are more than 4kb 
away (Figure 2.5A). Although it is difficult to definitively assign target genes to 
CRMs, even the nearest gene to a noncoding DHS can be far away. Furthermore, 
53% (10,890) of protein-coding genes have at least one noncoding DHS in the 
embryo, and of these 17% (1,901) have complex regulation, with more than four 
noncoding DHS (Appendix Figure 2.3B). We thus provide additional evidence that 
C. elegans transcriptional regulation can be complex and controlled by relatively 
distant CRMs. 
Our data are highly resolved enough to identify protection from DNaseI 
cleavage in noncoding DHS and across C. elegans cis-regulatory motifs within 
them that appear to be sites of TF binding (Appendix Figure 2.4). 82% and 84% of 
embryo and L1 arrest noncoding DHS, respectively, were found to harbor TF 
footprints. We find numbers of noncoding DHS on the same order of magnitude as 
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Drosophila DNase-seq (roughly 20,000 noncoding DHS per stage) with similar 
depths of sequencing (Thomas et al. 2011). Our finding that L1 arrest noncoding 
DHS are 88% shared with embryo noncoding DHS are also similar to findings from 
Drosophila showing that most noncoding DHS are also similar to previous findings 
that show 78% concordance of DHS between Stage 5 and Stage 11 Drosophila 
embryos (Thomas et al. 2011). 
It is difficult to estimate the cellular resolution of DNase-seq data that we 
have generated from entire embryos or L1 arrest larvae. We were able to recover 
overrepresented motifs in DHS representing binding sites of TF regulators of the 
three most abundant tissues in C. elegans: muscle, neuronal, and intestine 
(Appendix3 D-E) as well as motifs that occur in a smaller number of tissues. 
Naturally, these data are likely composed of an average of DNase hypersensitivity 
profiles of different tissues. We were able to find novel regulatory motifs that at least, 
according to anatomy enrichment profiles, appeared to be enriched in relatively 
specific areas (e.g. AAAATTCMAAA enriched in head neurons; MAACAACAACAA 
enriched in ventral cord neurons; ACTACAAACTAC enriched in excretory cell; Table 
2.1) but it is very difficult to specifically attribute changes in gene regulation to a 
given spatial region within the embryo or L1 larvae without additional information. 
Thus we have evaluated our noncoding DHS in gene loci in the context of global 
changes in transcriptional regulation that are occurring between L1 arrest and 
embryo and in gene loci whose expression and regulation has been studied in the 
embryonic or L1 arrest context. In order to probe gene activity within a small 
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number of specific cell types we suspect it will become more feasible in the future 
to isolate tissues and use a similar technique such as ATAC-seq which can work with 
smaller amounts of starting material compared to DNase-seq. 
These DNase-seq maps of DHS and TF footprints will be useful for exploring 
and dissecting genome-wide regulation of genes active in the embryo and to 
discover novel regulatory factors and their potential sites of action. For example, 
we were able to use DNaseI data to refine and improve the prediction of 
tissue-specific genes by focusing on N1 (neuronal) and ELT-2, UNC-62, and SLR-2 
(intestinal) DNA motifs present within noncoding DHS in embryos. Putative CRMs 
and TF binding site data from this study will be available through WormBase. 
Comparative analysis of L1 arrest condition-specific noncoding DHS 
indicate many potential sites of cis-regulatory action in genes whose expression 
differs between the L1 arrest larvae and the embryo, as well as genes implicated in 
starvation response of L1 larvae and in specific target genes of DAF-16 and PHA-4 
transcriptional regulators downstream of signaling pathways involved in L1 arrest. 
Using our noncoding DHS, we identified 57 novel regulatory DNA motifs 
involved in developmental processes ranging from aging and reproduction to signal 
transduction, cell-cell-signaling, and behavior. Future experiments will be needed 
to assay the functional activity of these noncoding DHS and the role of TF 
footprints in controlling activity. DNase-seq may be applied to other nematode 
species whose genomes and transcriptomes are known, but whose regulation has 
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not yet been explored and for which transgenic assays will be extremely difficult. 
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Methods 
C. elegans culture and nuclei isolation 
C. elegans wild-type N2 worms were synchronized and grown in liquid 
culture (10 worms/uL and 20 mg/mL E. coli HB101 in S-complete) over at least 
two generations. Embryos around the 40-cell stage were obtained by bleaching 
adult worms and then frozen at -80°C. To obtain L1 arrest larvae, bleached 
embryos were resuspended in S. complete and allowed to hatch in the absence of 
food. Starved L1 arrest larvae were collected at 10 hours and frozen at -80°C. To 
isolate nuclei, samples were thawed and ground to fine powder with mortar and 
pestle over dry ice. Samples were reconstituted in nuclei purification buffer (0.1% 
Triton-X, spermine, spermidine, and protease inhibitor) and dounced for 30 
strokes (nuclei isolation protocol from INTACT method; Steiner and Henikoff et al. 
2015). Nuclei were collected by spinning 10 minutes at 0.1 g to separate from 
debris and visualized using DAPI. Nuclei were further purified by spinning 10 
minutes at 1000 g over a cushion of Optiprep (60% iodixanol) at 4°C. 
DNaseI treatment, DNA purification, and size-selection 
Embryo and L1 arrest larvae nuclei were treated with 0, 20, 40, 80, 120, 160 
U/mL DNaseI in 1X DNaseI digestion buffer (containing CaCl2, spermine, 
spermidine, protease inhibitor) each for 3 minutes at 37°C. DNaseI treatment 
follows the conditions from the Stamatoyannopoulos lab protocol (Thurman et al. 
2012). DNaseI treatment was quenched with STOP buffer containing 20mg/mL 
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Proteinase K and incubated 55°C overnight. After treating with 45ug/mL boiled 
RNase A for 30 minutes, DNA was purified and concentrated using column 
purification. The DNA sample was run on 1% agarose, stained with Sybr Gold, and 
the gel piece containing DNA fragments less than 500bp was purified. DNA yield 
was measured using a Qubit fluorometer. See Appendix 1 for adapted DNaseI 
protocol. 
QPCR quality control and measuring enrichment in regulatory region 
QPCR primers were designed against the conserved MUSSA regions of “true 
positive” N1, N2, N3, N4, N5, N7, N8, N9, N11 lin-39/ceh-13 enhancers and N5 and 
N6 negative control non-enhancer regions studied by Kuntz et al. (2008). 
(Appendix Table 2.1). QPCRs were performed with calibration of duplicate 
genomic DNA standards and absolute derivative measurement of Cp. Relative fold 
enrichment was compared within samples by normalizing measured concentration 
of each region vs. mean of negative controls (Appendix Figure 2.2). The sample 
from the DNaseI concentration harboring the highest measure of regulatory 
enrichment from each biological replicate was prepared into a library and 
multiplex sequenced on Illumina HiSeq to yield 50bp single end reads. 
Read alignment and quality control 
Reads were analyzed using FastQC and filtered using quality threshold Q20 
(Appendix Table 2.1). 50bp single-end reads from embryo replicates B, C, D and L1 
arrest X, Y, Z replicates were trimmed to 45bp and mapped to WS220 (ce10) 
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version of C. elegans genome using Bowtie 1.0.0 (Langmead et al. 2009) using 
settings that did not allow alignments with more than two mismatches, disallowing 
reads with more than two read alignments, and only permitting alignments in the 
best alignment “stratum”. 76bp single-end reads from embryo replicate A and L1 
arrest replicates W and V did not need trimming and were mapped using identical 
settings. Potential PCR duplicates were removed using software SAMtools (Li et al. 
2009). 50bp single end reads are of sufficient length for mapping reads to the 
C. elegans genome. 
Identification of DNaseI hypersensitivity peaks and TF footprints and 
annotation 
Raw DNaseI hypersensitive peaks were identified by detecting read 
enrichment in 150bp consecutive nucleotides using HOTSPOT peak caller 
specifically designed for DNase-seq (version 3; John et al. 2011). We filtered raw 
peak calls obtained from HOTSPOT using the irreproducibility discovery rate 
(IDR) framework developed for ENCODE, which uses a non-parametric copula 
mixture model to filter peaks into reproducible or irreproducible categories (Li et 
al. 2011; Landt et al. 2012). Peaks are selected on the combination of their rank or 
score as well as their consistency across replicates.  Peaks overlapping 
Repeatmasker repeats were omitted. In addition, blacklist regions from ENCODE 
that represent known ce10 genomic regions exhibiting signal artifacts in ChIP-seq 
experiments were filtered (ENCODE Project Consortium 2012). Overlapping peaks 
were also merged. 41,825 and 23,670 DHS peaks were thus found across embryo 
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and L1 arrest biological replicates, respectively. DHS peak locations were 
annotated in exons (if 75% of region was located in exon), introns, promoter 
(<300bp from ATG), and intergenic regions (>300bp from ATG) using custom 
scripts and WormBase WS241 gene models. Pseudogenes, tRNAs, and ncRNAs 
were excluded from annotation. 
Footprints were identified using DNase2TF software package (FDR 
threshold 0.05) (Sung et al. 2014) and BAM alignment files for each biological 
replicate in order to identify decreased read coverage within noncoding DHS in 
regions between 6-40bp with a strand shift in reads. Replicate data within each 
stage were merged and used to identify additional TF footprints. 
Annotation, statistics and data analysis were performed with custom scripts 
using Python, Ruby, R, Bash scripting, Bedtools (Quinlan and Hall 2010), Bedops 
(Neph et al. 2012), and pyBedTools (Dale et al. 2011). Visualization of read 
coverage over normalized gene lengths and k-means clustering was performed 
using DeepTools (Ramirez et al. 2014). 
Evaluating enrichment of enhancer marks, sequence conservation in 
noncoding DHS and gene expression 
Sequence conservation is measured by phyloP score across seven related 
Caenorhabditis species. 10,000 randomizations of noncoding DHS from embryo 
and L1 arrest larvae were performed and compared with observed median phyloP 
score. Fold enrichment of conservation was calculated against the 97.5th percentile 
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of median phyloP of randomizations. 10,000 randomizations of noncoding DHS 
from embryo and L1 arrest larvae and overlap with TSS (Chen et al. 2013), 
modENCODE HOT, CBP-1 embryo H3K4me3 and RNAP II regions (Gerstein et al. 
2010) was performed on each randomization and compared with observed median 
overlap. Fold enrichment of different types of marks (TSS, CBP-1, HOT, RNA Pol II 
and H3K4me3) in noncoding DHS is calculated against the 97.5th percentile of 
median overlap from randomizations. Null hypothesis testing was performed with 
one-sample, two-sided Kolmogorov-Smirnov (KS) tests. 
Embryo expression data (Zhong et al. 2010) measured in log2 of fragments 
per kilobase of exon per million fragments mapped (FPKM) was used to compare 
expression of higher vs. lower read coverage genes and between genes associated 
with different categories of noncoding DHS. Genes with varying numbers of 
noncoding DHS and with or without promoter-enhancer-associated marks were 
compared by measuring fold changes in expression in the embryo. In order to 
conservatively estimate magnitude of fold changes of expression, we adjust genes 
whose expression is below 0.01 FPKM to a more reasonably low level of 0.01 FPKM. 
 
Refining prediction of genes expressed in neuronal and intestinal 
datasets using cis-regulatory motifs located within embryo noncoding 
DHS 
FIMO (Grant et al. 2011) was used to identify sites of known cis-regulatory 
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motifs N1 (Ruvinsky et al. 2007), ELT-2 (McGhee et al. 2009), SLR-2 (Kirienko 
and Fay 2010) and UNC-62 (Van Nostrand al. 2013) within the 2kb 5’ and intron 
regions of C. elegans protein-coding genes using threshold p < 1x10-4. Of these 
motif sites, those that were located within noncoding DHS were noted. Genes 
associated with motif sites were compared against genes enriched in neuronal and 
intestinal expression datasets (neuronal tiling array data from McGhee et al. 2009; 
dissected adult intestinal SAGE data from McGhee et al. 2007; FACS embryo 
intestine tiling array data from Spencer et al. 2011). Percentage of genes correctly 
predicted by the presence of at least one motif (Motif Only) was compared to that 
of the presence of at least one motif located within noncoding DHS (Motif and 
Noncoding DHS). Regardless of number of motifs or noncoding DHS, each gene 
was counted only once if at least one was present. 
Average DNase read profile mapping across C. elegans cis-regulatory 
motifs 
FIMO (Grant et al. 2011) was used to identify sites of known cis-regulatory 
motifs within the 2kb 5’ regions of protein-coding genes in the C. elegans genome 
using threshold p < 1x10-4. For each site, DNase cleavage was measured from start 
of read alignment (taking into account strand orientation of each read alignment) 
across a window of 80bp surrounding and including the motif, using scripts 
included in the pyDNase package (Piper et al. 2013). In this manner, average 
DNase cleavage was calculated across thousands of sites for a given motif. 
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Motif discovery 
Motifs were identified within DHS peaks and footprints using DREME 
(Bailey et al. 2011) using E-value threshold 0.05. Entire sequences of DHS peaks 
and footprints greater than 10bp were used to identify motifs. For footprints less 
than 10bp, we included 5bp of neighboring genomic sequence. Motifs were 
compared to curated WormBase C. elegans motifs and promoter motifs from 
Grishkevich et al. (2011) using TOMTOM (Gupta et al. 2007) at thresholds of q<0.1 
and 0.05. Motif occurrences within noncoding DHS peaks were identified with 
FIMO using thresholds of q<0.05 and 0.025 (Grant et al. 2011). 
Gene Ontology and anatomy enrichment analysis  
Gene Ontology (GO) analysis was performed on the nearest gene using 
AmiGO (Gene Ontology Consortium 2000) using p-value threshold 0.05. Only the 
50 most enriched terms were considered. Enriched terms were parsed with ReviGO 
(Supek et al. 2011) to visualize term relatedness and predict biological and 
molecular function (Appendix Table 2.3). 
Anatomy term enrichment was measured using a permutation test for 
motif-associated genes. Anatomy annotation was obtained from WormBase and 
only terms with at least 100 genes associated with them were considered. We 
measured N number of motif-associated genes and counted anatomy terms 
associated with each gene. For each motif, we performed 105 permutations, 
randomly selecting N genes from the dataset, and measured the number of 
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associated anatomy terms. We then calculated anatomy enrichment probability 
for each motif, corresponding to the probability that the anatomy term appeared as 
or more frequently at random compared to observed value. Since lower probability 
indicates higher enrichment, we used a 0.05 probability threshold to select 
enriched anatomy terms for each motif. 
Differential condition comparison of gene expression between embryo 
and L1 arrest 
Differences in gene expression were analyzed by comparing normalized 
FPKM data from microarray datasets from Baugh et al. (2009) to compare 
expression between 6hr L1 starved larvae and embryos, and between 6hr starved L1 
larvae and 6hr fed L1 larvae. From expression comparisons we generated lists of 
genes: top quartile of genes upregulated in 6hr starved L1 larvae versus embryo, and 
top deciles of genes upregulated and downregulated in response to starvation when 
comparing expression observed between 6hr starved L1 larvae and 6hr fed L1 larvae. 
To compare gene expression associated with L1 condition-specific noncoding DHS 
with embryo condition-specific noncoding DHS, the L1 starved vs. embryo 
expression ratio of genes associated with each L1 or embryo condition-specific peak 
were tested with a two-sample, two-sided KS statistical test. 
Additional L1 analysis 
Statistical enrichment analysis of PHA-4 in L1 DHS was performed by testing 
10,000 randomized permutations of L1 DHS (all), noncoding DHS, and for 
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intersection with PHA-4 ChIP-seq peaks from L1 starved larvae stage (Zhong et 
al. 2010) and testing with the one-sample two-sided KS test. The following gene 
classes were identified within the L1 noncoding DHS by comparison with existing 
datasets: DAF-16 target genes (top 3000 DAF-16 target genes from list from Tepper 
et al. 2013), PHA-4 target genes (gene list of PHA-4 targets in L1 arrest from Zhong 
et al. 2010), and top quartile of genes upregulated in 6hr starved L1 larvae vs. 
embryo and top deciles of genes upregulated and downregulated in response to 
starvation between 6hr starved L1 larvae and 6hr fed L1 larvae (microarray 
expression data from Baugh et al. 2009). PHA-4 and DAF-16 motifs in specific gene 
loci were detected using FIMO (Grant et al. 2011) using p value thresholds of 5x10-5 
and 1x10-4, respectively. 
Resource and data access 
The following data will be made available through WormBase (data files are 
listed in Appendix Table 2.4). DNase signal tracks from merged sample from either 
embryo or L1 arrest are shown (total, positive-strand, and negative-strand reads), 
with additional corresponding tracks for each biological replicate. 2) Tracks for All 
DHS (post-IDR filtering), Noncoding DHS and TF Footprint regions for embryo 
and L1 arrest DNase-seq. 3) Gene annotations for each noncoding DHS. 4) L1 
condition-specific noncoding DHS and gene annotations. 5) Lists of novel motifs 
discovered (position-frequency matrices in MEME format. 6) Enriched Gene 
Ontology and anatomy terms and motif-associated genes for each motif. Read data 
will be deposited in the NCBI Short Read Archive (SRA).  
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Introduction 
Mass functional testing of enhancers in metazoans is a challenge, owing to the 
inefficiency of performing individual reporter gene assays. In this study I test 
methods for massively parallel reporter analysis of candidate Caenorhabditis 
elegans enhancers and see if we can functionally validate putative cis-regulatory 
modules (CRMs) from a systematic screen of DNase-hypersensitivity sites (DHS) in 
Caenorhabditis elegans embryos (Ho and Sternberg, submitted).  
I have taken two approaches inspired by two previous studies, massively 
parallel reporter assay (MPRA) and self-transcribed active regulatory regions 
sequencing (STARR-seq), previously performed in mammalian cell lines and 
Drosophila S2 cells, respectively (Melnikov et al. 2012; Arnold et al. 2013). In these 
studies, large numbers of putative enhancer sequences are generated as 
oligonucleotide libraries and cloned into individual constructs. These constructs are 
then pooled and used to test the ability of these sequences to drive reporter gene 
expression in transiently transfected cell lines. DNA and poly-adenylated (poly-A) 
RNA are simultaneously extracted from transfected cells, fragmented, and 
sequenced via shotgun sequencing. Each candidate enhancer sequence can be 
identified in the RNA and in the DNA by its sequence (in the case of STARR) or 
associated unique barcode (in the case of MPRA). These studies thus utilize high 
throughput sequencing as a cheap and powerful readout of functional activity of 
enhancer-driven transcription. 
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The MPRA approach  used a mixture of custom single strand (ss) DNA 
oligos synthesized in parallel on oligo arrays as a source of sequences for the 
enhancer libraries, which is versatile and relatively cheap (Melnikov et al., 2012). 
While these custom oligos are currently limited to only a few hundred base pairs in 
length, oligos around 200bp in size should be sufficient for testing the typical size of 
Caenorhabditis elegans enhancers. Using custom oligos also allows the variation of 
sequence within the library to test point mutations or larger changes in sequence 
and observe the effect on function. The oligos are then designed to include unique 
barcodes associated with each enhancer sequence, such that the barcode is encoded 
downstream of the reporter gene and will be present in the resulting mRNA 
transcript. The presence of the barcode thus indicates that the associated enhancer 
was able to drive reporter gene expression. Furthermore, designing custom oligos 
with sequence tags flanking the sequence enables multiplexed synthesis of separate 
libraries of oligos that can be individually amplified from the mixture using primers 
designed against the sequence tags. 
  In the STARR-seq study by Arnold et al. (2013) the putative enhancer 
sequence is cloned downstream of the reporter gene, so that if it is able to activate 
transcription of the reporter gene, the enhancer itself is transcribed as well. This 
assay design allows direct detection of the enhancer sequence in the RNA-seq data, 
and removes the need for unique barcodes for each enhancer sequence. The 
published STARR-seq research used fragmentation of genomic DNA as the source of 
putative enhancer sequences. While this is convenient, cheap and relatively unbiased 
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as a method of obtaining sequences, it does not allow control of the exact 
sequences to be tested and does not enable selective mutational analysis of the 
sequences. However, it does allow longer sequences to be tested in the assay and the 
results are especially useful for defining the boundaries of enhancer activity since the 
read profile around STARR-seq peaks should reflect the boundaries of sequences 
that are able to drive expression. 
There are a few potential caveats in doing these types of parallel assays. It is 
still unknown whether, when testing these sequences in parallel, there is complete 
independence between individual reporters on a transgene array or if there are any 
potential interactions between reporters. This is important to consider when 
applying these approaches to C. elegans since injecting transgenic reporters into 
C. elegans generates extrachromosomal arrays with complex and heritable structure 
with rearrangement and recombination (Mello et al. 1991). Another important 
consideration is whether these assays are able to give quantitative information as 
well as qualitative information about enhancer activity. In the MPRA study in 
mammalian cell lines, Melnikov and colleagues (2012) were able to systematically 
dissect a synthetic cAMP-regulated enhancer (CRE) and a virus-inducible enhancer 
of human interferon-β (IFNB) using scanning mutagenesis across the sequences of 
these enhancers and testing effects of these mutations on enhancer activity. 
Enhancer activity was measured by the abundance of barcodes in RNA-seq data and 
was normalized to the representation of the barcodes in DNA. In STARR-seq, Arnold 
and colleagues compared the activity of different enhancers using similar methods of 
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normalization to DNA. Both of these studies were performed in cell lines whose 
uniformity of cell type facilitated gathering of quantitative information. Application 
of these assays to a multicellular system containing many different tissues and cell 
types, as in the case of transgenic Caenorhabditis elegans, will make quantitative 
comparison challenging, since sequences are likely to function as enhancers in some 
tissues but not others. However, even qualitative information from MPRA and 
STARR in C. elegans as to whether test sequences are able to function as enhancers 
will be very useful, since it will allow high throughput parallel screening. Enhancers 
that show significant activity above threshold in MPRA or STARR can be isolated for 
individual characterization. 
Our assay design in C. elegans makes use of 200bp single stranded custom 
DNA oligos synthesized on microarrays by Agilent. I designed our oligo order to 
contain 27,000 oligo sequences with approximately 108 copies of each individual 
oligo. I used 7bp unique barcodes, each present in two copies as a tandem repeat (we 
henceforth refer to this as the 2x7bp barcode). I disallow A at positions 2 and 5 
within the barcode so as to avoid a polyA signal in the barcode, giving a maximum of 
9216 barcodes possible within each library. The purpose of providing two tandem 
copies of the 7bp barcode is to guard against potential sequencing errors. 
Each C. elegans MPRA oligo contains 120bp of test enhancer sequence 
followed by a spacer and paired barcodes, flanked by library amplification tags 
(Figure 3.1). The final reporter construct positions the 120bp test enhancer sequence 
upstream of minimal ∆pes-10 promoter sequence followed by gfp reporter gene, the 
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unique 2x7bp barcode, and the 3’ UTR sequence from the C. elegans gene rla-1, 
which encodes a ribosomal subunit essential for animal viability likely to be 
expressed in all cell types (Sönnichsen et al. 2005). The ∆pes-10 promoter is a 
deleted promoter that is sensitive to enhancer activities commonly used in 
C. elegans enhancer assays (1995 Fire Vector Kit3). If the test enhancer is able to 
drive reporter gene expression, its associated barcode will also be transcribed and 
detectable in the RNA-seq data. 
 
                                                 
3 Dr. Andrew Fire, https://www.addgene.org/firelab/ 
 
Figure 3.1 Custom oligo design and reporter construct for C.  elegans MPRA scheme, 
based on Melnikov et al. (2012) 
C. elegans MPRA oligos are designed to test 120bp of sequence for enhancer activity. Sequence tags 
are 19bp apiece, with a 12bp spacer. The rla-1 3’ UTR includes some genomic sequence and is 67bp in 
length. 
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Each C. elegans STARR oligo contains 100bp of test enhancer sequence, 
along with a uniquely associated 2x7 bp barcode and the 3’ UTR from rla-1, flanked 
by library amplification tags (Figure 3.2). The final reporter construct positions the 
unique 2x7bp barcode, the rla-1 3’ UTR, and the 100bp test enhancer downstream of 
the ∆pes-10 minimal promoter and gfp reporter gene, so that the barcode is 
transcribed and detectable in RNA-seq data. 
 
My experimental libraries were designed to test putative enhancer sequences 
from DNase hypersensitivity sites previously found in C. elegans embryos (Ho and 
Sternberg, submitted). I designed a pilot set of 3,056 oligos each for the MPRA and 
STARR schemes containing individual libraries for noncoding DHS near hypoxia-
regulated and uniquely expressed gut genes and separate individual libraries for 
versions of these noncoding DHS with mutations in predicted HIF-1 binding sites or 
 
Figure 3.2 Custom oligo design and reporter construct for C. elegans STARR scheme, 
based on Arnold et al. (2013) 
C. elegans STARR oligos are designed to test 100bp of sequence for enhancer activity. Sequence tags 
are 19bp apiece and the rla-1 3’ UTR is 48bp in length. 
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motifs of intestinally-regulated TFs (ELT-2, MAB-3, DAF-16, SLR-2, SKN-1, 
TRA-1) (Table 3.1). HIF-1 is an ortholog of mammalian hypoxia-induced factor HIF-
1, and is required for survival in low-oxygen environments (Jiang et al. 2001). In 
addition, I also designed two additional libraries apiece for MPRA and for STARR in 
order to test 38% of the 26,644 putative CRMs that I identified in C. elegans 
embryos (see Chapter 2). I chose to use hypoxia genes and uniquely expressed gut 
genes in order to facilitate comparison of the results of MPRA or STARR assays in 
transgenic worms in normal conditions or with changes to their environment. For 
example, we could expose worms to hypoxic conditions (24 hours in low oxygen 
conditions such as 1% O2) or changes in diet, such as feeding them DA1877 strain of 
Comamonas, a bacterial food source which has been shown to induce many diet-
induced phenotypic effects in C. elegans compared to feeding worms the OP50 
strain of E. coli (MacNeil et al. 2013 a,b). 
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Materials and Methods 
For both MPRA and STARR approaches in C. elegans, oligo libraries are PCR 
amplified using primers designed against library tags (Figure 3.3). Then they are 
cloned into base reporter vectors (see Figures 3.4 and 3.5 for details). Plasmid DNA 
is then prepared from pooled transformants. A Δpes-10::gfp reporter cassette is then 
cloned into the relevant restriction sites of the collected plasmids containing MPRA 
oligos, and plasmid is prepared from the resulting pooled transformants. Having 
now completed the STARR and MPRA libraries, each is linearized by AsiSI digest. 
Each wild-type (WT) or mutant oligo library of hypoxia and gut enhancers was 
synthesized in separate libraries, so that WT and mutated versions of candidate 
enhancers could be separated into different libraries and thus limit the chances for 
mispriming and template switching during PCR amplification. Once reporter 
assembly is complete, these paired libraries will be combined for injection.  
Libraries of linearized constructs will be injected into the gonads of young 
adult C. elegans pha-1 (ts) hermaphrodites at a concentration of roughly 20-40 
ng/uL linearized transgene with approximately 20 ng/uL of pha-1 rescue construct 
and 60 ng/uL of carrier DNA. The carrier DNA is used to minimize the incidence of 
individual reporters directly abutting one another and help maintain the 
extrachromosomal array (Evans 2006) and will be composed of DNA ladder or 
possibly digested C.  elegans genomic DNA with AsiSI-compatible ends. Depending 
on success of microinjection and transgene maintenance Hillel may adjust the 
concentrations of the transgene injection mixture. The temperature-sensitive mutant 
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pha-1(e2123) is viable at 15°C but is inviable at 25°C, allowing us to use it as a 
selective marker (Granato et al. 1994). Injected worms are grown at 25°C; transgenic 
F1 animals rescued for the pha-1 phenotype are picked and used to establish stable 
transgenic lines, which are tracked to ensure that they arise from different injected 
P0s and represent independent transgenesis events. Transgenic worms are pooled 
from individual transgenic lines and mixed stages are isolated from these pools and 
simultaneous extraction of DNA and polyA RNA is performed. DNA and polyA-RNA 
samples are fragmented. In the case of polyA RNA, priming with universal primers 
to generate cDNA will be performed. Then fragmented DNA and cDNA samples will 
be prepared into libraries and multiplex sequenced on a HiSeq II (Illumina, San 
Diego, CA) using single-read shotgun sequencing. 
Reads below quality threshold Q20 using FastQC4 will be removed for quality 
control. I will then align reads to a database of our linearized reporter constructs 
using Bowtie to identify reads that align to our database, and remove any unaligned 
reads (which may come from genomic DNA, endogenous RNA transcripts, or 
contaminant RNA/DNA). 
For MPRA and STARR reads, I will count the representation of barcodes in 
the DNA and RNA-seq reads and we will normalize the count detected for each 
barcode in the RNA-seq data to the relative abundance of that barcode in DNA 
reads. I will use DNA read alignment to the database of linearized reporter 
constructs to estimate representation of test enhancers in the extrachromosomal 
                                                 
4 http://www.bioinformatics.babraham.ac.uk/projects/fastqc/ 
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array. I will consider enhancers and barcodes that are detected in the DNA-seq 
data but whose barcodes do not appear in the RNA-seq data above the threshold set 
by our negative control (non-enhancer test sequences; see Table 3.2) to be inactive 
under the conditions tested. Those enhancers and barcodes that appear in the DNA-
seq data and whose barcodes appear in the RNA-seq data above the threshold set by 
non-enhancer negative control sequences will be considered enhancers. I will 
compare WT and mutant libraries to determine if there are differences as a result of 
the mutations in HIF-1 or intestinal TF motifs in test enhancers.  
Custom scripts to assemble the unique 7bp barcode sets and to construct 
oligo sequences were written in Ruby with biopieces5 and Bash with BEDTOOLS 
(Quinlan and Hall 2010). Since our cloning scheme for the oligos makes use of 8-
cutter REs PacI, NotI, AscI, AsiSI, all sequence tags, spacers, 3’ UTRs and plasmid 
backbones were chosen to be free of these RE sites and enhancer sequences were 
cleared of these RE sites with 1-2bp mutations. 
                                                 
5 https://code.google.com/p/biopieces/ 
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Figure 3.3 Experimental scheme for MPRA and STARR in C. elegans 
Primers corresponding to sequence tags for each library are used to amplify the library (orange 
library being amplified, green library is not amplified in this example). Test enhancer sequences 
on each oligo are shown in yellow with a uniquely associated barcode in red. 
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I designed our oligos to test enhancers by taking the central 100bp (in the 
case of STARR) and 120 bp (in the case of MPRA) of noncoding DNaseI 
hypersensitive sites (DHS) from C. elegans DNase-seq data from embryos (Ho and 
Sternberg, submitted). DNase-seq uses high throughput sequencing of DNaseI-
treated chromatin to identify noncoding regions of a few hundred base pairs in 
length in the C. elegans genome that are accessible to DNaseI cleavage and which 
represent putative cis-regulatory modules. To obtain test enhancers for the gut and 
hypoxia oligo libraries, I took lists of genes expressed in the intestine (McGhee et al. 
2007), filtered to remove genes in muscle and neuronal tissue datasets (muscle and 
neural SAGE from Meissner et al. (2009)), and genes regulated by hypoxia either in 
a HIF-1 dependent or independent manner (Shen et al. 2005). I then selected 
embryo noncoding DHS located in the 2.5kb region surrounding these genes (Ho 
and Sternberg, submitted) for test enhancers in wild type (WT) libraries (Table 3.1). 
For mutant libraries, 8bp mutations were made in the sequences of any ELT-
2 (McGhee et al. 2009), MAB-3 (Yi and Zarkower 1999), DAF-16 (Furuyama et al. 
2000), SLR-2 (Kirienko and Fay 2010), SKN-1 (Blackwell 1994), or TRA-1 (Zarkower 
and Hodgkin 1993) motifs found in gut noncoding DHS and any HIF-1 motifs found 
in HIF-1 dependent hypoxia noncoding DHS (Table 3.1). 
For the oligo libraries to test the majority of noncoding DHS found in 
C. elegans embryos, I removed the lowest 10% scoring noncoding DHS. From the 
remaining 90% noncoding DHS, I randomly selected 10,196 noncoding DHS, 
representing 38% of the total embryo noncoding DHS. 8,000 of these noncoding 
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DHS were used to design embryo DHS library A and 2,196 were used to design 
embryo DHS library B (Table 3.1). 
 
I also selected regions to use as controls in our oligo set. These included 79 
embryo noncoding DHS near additional gut-expressed genes not otherwise 
represented in the library, and four negative control sequences within the N5 and N6 
 
Library Number of regions 
Total oligos in library 
MPRA – Hypoxia – WT  364† 538‡ 
MPRA – Hypoxia – mutant 53 177 
MPRA – Gut – WT 1,908 2,082* 
MPRA – Gut – mutant 135 259 
STARR – Hypoxia – WT 364† 538‡ 
STARR – Hypoxia – mutant 53 177 
STARR – Gut – WT 1,908 2,082* 
STARR – Gut – mutant 135 259 
MPRA2 – embryo DHS A 8,000 8,124 
MPRA2 – embryo DHS B 2,196 2,320 
STARR – embryo DHS A 8,000 8,124 
STARR – embryo DHS B 2,196 2,320 
Total 25,312 27,000 
Table 3.1 List of MPRA and STARR oligo libraries. 
For every oligo library there are 124 control sequence oligos (see Table 3.2). WT refers to wild-type. 
† includes 179 HIF-1 dependent and 185 independent noncoding DHS sequences 
‡ includes 50 duplicate Hypoxia WT (HIF-1 dependent) noncoding DHS sequences with unique 
barcodes, see explanation below 
* includes 50 duplicate Gut WT noncoding DHS sequences with unique barcodes, see explanation 
below 
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non-enhancer regions tested by Kuntz et al. (2008). I also included 41 embryo 
noncoding DHS within known enhancers from ceh-13, lin-39, myo-2, hlh-1, and lin-
26 loci (Table 3.2). 
I also duplicated 50 of the test enhancer sequences in each of the gut WT and 
hypoxia WT libraries (Table 3.1) with additional unique barcodes as a control for 
reproducibility of measured enhancer activity between constructs using different 
barcodes. 
 
Control regions Number of regions 
Positive Controls (DHS of additional gut-expressed genes) 79 
Negative Controls (Kuntz et al. 2008 negative regions) 4 
Other Controls (ceh-13/lin-39 Hox enhancers, myo-3, myo-2, 
hlh-1, lin-26 regulatory regions) 
41 
 
Table 3.2 List of control sequence oligos added to every library 
A total of 124 control sequence oligos are added to every MPRA or STARR library with unique 2x7bp 
barcodes. Four negative control regions within N5 and N6 non-enhancers found by Kuntz et al. 
(2008) were included, along with 79 positive controls of noncoding DHS of additional gut expressed 
genes not included in the gut gene set and 41 other controls of noncoding DHS corresponding 
mapping to regulatory regions of well-studied C. elegans genes. 
 
The set of unique 7bp barcodes (repeated in tandem in order to guard against 
sequencing errors, referred to as 2x7bp) were designed with no adenine (A) allowed 
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in positions 2 and 5 within the barcode to prevent any poly-A signal in the 
barcode. This resulted in 9216 possible unique barcodes in a given library. Each oligo 
library used unique barcodes within this set, but we re-used barcodes between 
different oligo libraries, although not between hypoxia and gut or between wild-type 
and mutant iterations of the same library. Each oligo library is amplified from the 
mixture of 27,000 custom oligos using unique forward and reverse primers 
corresponding to Tag 1 and reverse complement of Tag 2 flanking oligo sequences 
(Table 3.3).  
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Primer Set Forward (Sense of Tag1) Reverse (RC of Tag2) 
MPRA – Hypoxia – WT  ACTGACCCTGACCCTGACC TCCTGTGCCTGTGCCTGTG
MPRA – Hypoxia – 
mutant 
ACCAGGACCAGGACCAGAC AGGAGCAGTAGCAGGAGCC
MPRA – Gut – WT ACACAGCCACAGCCACAGC CAGACGGAGACGGAGACGG
MPRA – Gut – mutant TTGGTCCTGGTCTTGATCG TCCGACTCTGGCTCTGTCG
STARR – Hypoxia – WT TCTCTGCCTCTGCCTCTGC TCAGTCCCAGTCCCAGTCC
STARR – Hypoxia – 
mutant 
ACGGTCACGGTCACAGTTC AGCCAGAGCAAGAGCCAAG
STARR – Gut – WT AGGACACGGACACGGACAC TACACCGACACCGACACCG
STARR – Gut – mutant CGTCCTCGACCTCGTAATG TGACCTGGACCTTGACCTC
MPRA2 – embryo DHS A GAAGGGCTGGGAAGACACC TCCCATCGGTAGCGTGGAG
MPRA2 – embryo DHS B GCTGGCTTGGCGAATGTGC CGGTTCGGATCGAGGCTTC
STARR – embryo DHS A CCGACCACGACTCAACTGG GGACCGGAGTGCTGTCTAC
STARR – embryo DHS B GCCGCACTCTCACCTACTC GAGGCAGGCACTTCGGTTG
 
Table 3.3 Sequence Tags for oligo libraries 
Each sequence tag is 19bp and amplification primers are designed  
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Preliminary Results 
I prepared the noncoding DHS sequences and mutations, wrote scripts, and 
constructed oligo libraries for manufacture by Agilent. We have received the custom 
oligos and are presently in the cloning stage and sample preparation of the project, 
which will be largely handled by my co-author Dr. Hillel Schwartz. I will analyze all 
resulting DNA and RNA-seq sequence data and write a computational pipeline for 
all subsequent analyses. 
The detailed cloning scheme for C. elegans MPRA is as follows (Figure 3.4). 
Hillel has generated the base MPRA vector by cloning the rla-1 3’UTR into 
Bluescript using NotI and BamHI sites. He has PCR amplified MPRA oligo libraries, 
adding NotI and AsiSI sites and will clone the library into the prepared base MPRA 
vector which has been digested with NotI and PacI. This is possible because AsiSI 
ligates to PacI and results in a site that is not recleavable by either PacI or AsiSI. He 
has PCR amplified ∆pes-10::gfp from L4053 and will clone the reporter gene 
cassette into the cloned oligo MPRA library. 
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Figure 3.4 Cloning scheme for C. elegans MPRA oligos 
The orange asterisk (*) refers to the site which remains after AsiSI ligates to PacI and which is not 
recleavable by either enzyme. The AsiSI site present in the base MPRA vector and resulting reporter 
construct is roughly 200bp downstream from the rla-1 3’ UTR and is used to linearize the construct 
prior to injection. 
 
The detailed cloning scheme for C. elegans STARR is as follows (Figure 3.5). 
Hillel has generated the base STARR vector by cloning a NotI and AsiSI cassette into 
L4053, replacing the unc-54 3’UTR. He has PCR amplified the STARR oligo library, 
adding NotI and AsiSI sites. He will clone the library into the STARR vector using 
NotI and PacI sites in the vector, which is possible because AsiSI ligates to PacI and 
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results in a site that is not recleavable by either PacI or AsiSI. The reporter 
construct libraries are then linearized by digest with AsiSI to a site that is around 
200bp downstream of Tag 2. 
 
Figure 3.5 Cloning scheme for C. elegans STARR oligos 
The orange asterisk (*) refers to the site remaining after AsiSI ligates to PacI and which is not 
recleavable by either enzyme. The AsiSI site present in the final STARR reporter construct is roughly 
200bp downstream from Tag 2 and is used to linearize the construct prior to injection. 
 
Our findings from cloning a previous oligo set found that oligos that truncate 
during synthesis and that remain in the mixture can generate polymerization 
products that amplify off of other templates. Thus our current experimental design 
has been revised to clean up the oligo mixture and minimize any unnecessary PCR 
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amplification. We linearize the plasmid using restriction enzyme digest instead of 
PCR amplification. We are also size-selecting the oligo library to remove some 
truncated oligos using an SPRI-style method. In the presence of a “crowding agent” 
polyethylene glycol and NaCl will allow negatively charged DNA (in this case, 
ssDNA) to bind to carboxyl groups on a paramagnetic bead surface. We use a 150bp 
size selection kit from NVIGEN, but it is equivalent to Solid Phase Reversible 
Immobilisation (SPRI) and Ampure (Beckman Coulter) kit protocols (DeAngelis et 
al. 1995). We have altered our oligo design such that any homologous sequence or 
fixed region among oligos is on the 3’ end. We have designed our mutant sequences 
to be in separate oligo libraries from wild-type sequences to prevent any potential 
mixing up of barcodes within the library. Finally, we use an excess of primers in PCR 
to shift the equilibrium towards DNA synthesis from free primer and template 
instead of annealing of partial products. 
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C h a p t e r 4  
Application of DNase-seq to an entomopathogenic nematode, 
Steinernema carpocapsae 
Introduction 
 Having demonstrated proof-of-principle DNase-seq in C. elegans, I am 
applying the technique to study Steinernema carpocapsae, a distant nematode 
relative.  S. carpocapsae and related nematodes of the Steinernema genus are a class 
of parasitic nematodes called entomopathogenic nematodes (EPNs) that have 
evolved an association with insect-pathogenic bacteria (reviewed in Dillman and 
Sternberg, 2012). Together, the nematode, acting as a vector, and its mutualistic 
bacterial pathogen, are able to rapidly kill their insect hosts. This distinctive 
association between nematode and bacterial pathogen is found among many 
nematode species, but are best studied in two genera, Heterorhabditis and 
Steinernema. EPNs have a lifecycle in which infective juvenile (IJ) stage individuals 
seek out and infect an insect host and release their payload of insect-pathogenic 
bacteria into the nutrient-rich internal environment (Figure 4.1). The bacteria 
proliferate and rapidly kill the host, creating an ideal environment for the nematodes 
to develop and reproduce. When all resources in the insect host have been 
consumed, the new generation of IJs is able to escape from the dead host and seek 
out the next insect host. The EPN lifestyle appears in several multiple distantly 
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related genera including Steinernema, Heterorhabditis and reportedly Oscheius 
as well (reviewed in Dillman and Sternberg 2012 and Dillman et al. 2012c). 
 
 Nematode species in the Steinernema genus are members of Clade IV and 
share with Caenorhabditis elegans a common ancestor that lived several hundred 
 
Figure 4.1 Lifecycle of entomopathogenic nematodes (EPNs) 
The infective juvenile (IJ stage) is a developmentally arrested third-larval stage of EPNs that is stress-
resistant and the only stage that is free-living. IJs seek out and infect insect hosts, releasing insect-
pathogenic bacteria once inside. The insect pathogenic bacteria rapidly proliferates and  kills the 
host. In the host, IJs develop into adults and will reproduce. When all resources are used, a new 
generation of IJs will develop and emerge from the cadaver to seek new hosts. Figure adapted from 
Dillman and Sternberg 2012. 
  
144
million years ago (Figure 4.2; Dillman, Macchietto, submitted). While most 
C. elegans are hermaphrodites, Steinernema species are gonochoristic. Steinernema 
nematodes are a fascinating model for insect parasitism as well as for bacteria-host 
associations. Studies in S. carpocapsae and other EPNs have shed light on olfaction 
and host-seeking behavior of parasitic nematodes (Hallem et al. 2011; Dillman et al. 
2012a). 
Five Steinernema species (S. carpocapsae, S. feltiae, S. glaseri, S. 
monticolum, S. scapterisci), of which are all EPNs, have had their genomes and 
transcriptomes sequenced (Dillman, Macchietto et al. Submitted). These data allow 
evolutionary comparisons to be made among Steinernema species to locate 
protein-coding genes that may facilitate parasitism within this group, mechanisms 
that facilitate partnership between mutualistic Xenorhabdus bacteria and the 
Steinernema host nematode, and differences among Steinernema species in their 
host range and responses to different host odors (Dillman et al 2012a). Furthermore, 
important comparisons can be made to the best studied nematode species, 
C. elegans. An example of this is comparison of the Hox genes, which are an 
important class of transcription factors that regulate development in metazoans. 
Nematodes have lost many Hox genes compared to metazoan (Aboobaker and 
Blaxter a,b) but between C. elegans, Panagrellus redivivus, and the five 
Steinernema species, there appears to be good conservation among five of the six 
C. elegans Hox genes (ceh-13, lin-39, mab-5, egl-5, and php-3), whereas nob-1 
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appears to have been lost in these species (Figure 4.3; Dillman, Macchietto et al. 
Submitted). 
 
Figure 4.2 Phylogenetic position of Steinernema carpocapsae in Nematoda. EPNs are 
shown in red.  Steinernema carpocapsae is in Clade IV, while Heterorhabditis bacteriophora and 
Caenorhabditis elegans (shown in blue) are in Clade V. Other nematodes in Clades I through V 
are shown in black, as well as non-nematode outgroup species. Figure adapted from Hallem et al. 
2011. 
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Studies of conservation of noncoding DNA between C. elegans and 
Steinernema gene orthologs have elucidated many novel conserved noncoding 
regulatory motifs (Dillman, Macchietto et al. Submitted). There is otherwise little 
known about cis-regulatory sequences in Steinernema nematodes. Returning to the 
example of the Hox genes, the 22kb intergenic region between lin-39 and ceh-13 Hox 
genes in C. elegans has been well-studied by Kuntz and colleagues (2008) who 
characterized 11 enhancers (N1-N4, N7-N11, I4 and I8) that were able to drive gene 
expression in transgenic reporter assays. In S. carpocapsae, the lin-39/ceh-13 
intergenic region is much larger at around 35kb, and harbors multiple additional 
protein-coding genes which do not appear to be related in function to the Hox genes 
(Figure 4.4). It would be very interesting to examine whether these lin-39/ceh-13 
enhancers found by Kuntz and colleagues (2008) possess orthologs in S. 
carpocapsae and are functionally conserved in their ability to drive either lin-39 or 
ceh-13 expression. 
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DNase-seq, a method that uses high-throughput sequencing of DNaseI-
treated chromatin, is able to identify regions of a few hundred base pairs long as 
putative cis-regulatory sequences and has been successfully tested in C. elegans (Ho 
and Sternberg, submitted). I was able to identify seven (N1-N4, N8, N10, N11) out of 
nine conserved enhancers using DNaseI hypersensitive sites (DHS) I observed in C. 
elegans embryos, in addition to two additional enhancers (I4, I8) that were also 
identified by Kuntz and colleagues (2008) but which were not highly conserved on 
the sequence level. I have been applying DNase-seq to S. carpocapsae IJs in order to 
identify and study cis-regulatory sequences in this distantly related nematode which 
is new to the study of functional regulatory genomics. The IJ stage is the most easily 
collected stage of S. carpocapsae and is of particular interest because of its well-
characterized host-seeking behavior. 
  
C. elegans 
Hox genes  S. carpocapsae  S. feltiae  S. glaseri  S. monticolum  S. scapterisci  P. redivivus 
ceh‐13  X  X  X  X  X  X 
lin‐39  X  X  X  X  X  X 
mab‐5  X  X  X  X  X  X 
egl‐5  ?  X  ?  X  X  X 
php‐3  X  X  X  X  X  X 
nob‐1  ‐‐  ‐‐  ‐‐  ‐‐  ‐‐  ‐‐ 
 
Figure 4.3. Conservation of Hox genes in Steinernema nematodes 
Five out of six C. elegans Hox genes appear to be conserved in Clade IV Steinernema and 
Panagrellus nematodes. Hox gene nob-1 appears to have been lost. Adapted from Dillman, 
Macchietto et al. (submitted). 
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Materials and Methods 
 
Steinernema carpocapsae nematodes (strain All) were grown and 
maintained using standard culture methods (White 1927). In this culture method, 
five last-instar larvae of the waxmoth (Galleria mellonella) were placed on top of a 
disc of 55 mm Whatman 1 filter paper to serve as a pseudo-soil substrate in a 5 cm 
Petri dish. 300l containing 500-1000 S. carpocapsae IJs suspended in water was 
evenly distributed on the filter paper to infect the waxmoth larvae. After 7-10 days 
the insect cadavers were transferred to White traps, in which IJs would emerge after 
3-5 days (White 1927). Emerging IJs were collected and washed for 30 minutes in 
0.4% Hyamine 1622 solution (Fluka), rinsed three times with water, and then once 
with 1X PBS. IJs were then frozen at -80°C. Ten to fifteen plates of S. carpocapsae 
were prepared at a time, yielding roughly 1.5 to 2 mL of packed IJs. 
S. carpocapsae IJs were thawed and ground to fine powder with mortar and 
pestle over dry ice to break IJs open and isolate nuclei. Samples were reconstituted 
in nuclei purification buffer (0.1% Triton-X, spermine, spermidine, and protease 
inhibitor) and dounced for 30 strokes with a tight-fitting pestle on ice (nuclei 
isolation protocol from INTACT method; Steiner and Henikoff et al. 2015). Samples 
were spun at 0.1 g for 10 minutes to separate from debris, and purified further by 
spinning 10 minutes at 1000 g over a cushion of Optiprep (60% iodixanol) at 4°C. 
Isolated nuclei were visualized using DAPI staining. 
Equal aliquots of S. carpocapsae IJ nuclei were treated with 0, 20, 40, 80, 
  
149
120, 160 U/mL DNaseI in 1X DNaseI digestion buffer (containing CaCl2, 
spermine, spermidine, protease inhibitor) for 3 minutes at 37°C. DNaseI digestion 
conditions follow the Stamatoyannopoulos lab protocol (Thurman et al. 2012). 
DNaseI digestion was quenched by adding STOP buffer containing 20mg/mL 
Proteinase K and incubating 55°C overnight. The samples were then treated with 
45ug/mL boiled RNase A for 30 minutes. DNA was purified and concentrated 
using column purification and run on 1% agarose gel stained with Sybr Gold. The 
gel piece containing DNA fragments less than 500bp in size was purified. DNA 
yield was measured using a Qubit fluorometer. See Appendix 1 for adapted DNaseI 
protocol. 
QPCR primers (Table 4.1) were designed against S. carpocapsae sequences 
from lin-39/ceh-13 Hox intergenic regions showing conservation in 23 out of 30 
consecutive nucleotides using multi-species sequence analysis using ungapped 
transitive alignments (MUSSA) analysis between S. carpocapsae and C. elegans 
(Figure 4.5). Six “negative” control regions from the lin-39/ceh-13 Hox complex 
were chosen that were not conserved between S. carpocapsae and C. elegans and 
between S. carpocapsae and S. feltiae. In addition, QPCR primers were also 
designed against 100bp upstream noncoding “promoter” regions of predicted S. 
carpocapsae FAR (fatty acid- and retinol-binding protein) genes that are known to 
be highly expressed in IJ stage: g24938 and g8883 (Dillman, Macchietto et al., 
submitted). QPCR amplicon sizes ranged from 70bp to 97bp.  
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Primer Forward Reverse Amplicon Size (bp) 
g24938 TCGCTTTTGTGTTTCTCTAATTGAA 
TGGTTGTAAAGAAGA
CGGTTGG 75 
g8883 TGGATTCGGAACAGGAAAAA 
AGTTCACGACCGCTG
CTAGT 70 
N3_3 GTGACTACCCGTTGACACCTG 
GGAAGTTTCAGAAAA
CGATGGA 77 
N3_3 
lin-39 
proxima
l 
GTAGTCCGAGGACG
GGTTAAG 
AGTCTCTCTTCTCGCC
TGAATCT 89 
N7_1 CAGAGAACGCGTGATTGTTG 
GTTCCAAGCCACCTTT
CCTT 83 
I8 AGCAATCCTATGGAATTCTCCAC 
AGCGTTACAAAAATT
GCCAAAA 90 
N9 3' GGCTTCAAAGCAAGAAATATCAAT 
CAGCAGCCCGAATTTT
CATA 80 
N10_1 GGGTGACCTGTAGCCGTTTT 
CGAACTCCGTCCGTAT
CACT 83 
N10_2 GAGGGAGCGGAGATAACGAT 
TGTAAATGCGCCTCCT
TACC 75 
N11 TCGATCGCAAAAGAAGAGTTG 
CTCCCATCAGAGTTCC
AACAA 77 
Neg1 AGGCGATCGAGGAAGAAGAG 
TGAATCCGTTTTCCTC
CAAG 97 
Neg4 ATGGCGCAAGGATTTGAGTA 
GTGCAGGCGACTTGC
AGAT 94 
Neg7A ACGTCGTCTGGTTAGGATGTG 
TGTTCAGAACGCCATC
TTTGT 90 
Neg8A AGCTGGACGATTGTTTGAGG 
GACGCGATGCACTTC
GTATT 76 
Neg9A TGGTATCAAGATCTCCGTGTGA 
CAGGCGTTGATGGAT
GTTCT 78 
Neg9B TCGACGCCCATTAATTAGATCA 
TGATACCAGTGTTGG
TTAACATGC 79 
 
Table 4.1 QPCR primers for S. carpocapsae DNase-seq 
QPCR primers are designed against the promoters of two FAR genes, eight conserved 
noncoding regions in lin-39/ceh-13 intergenic region, and six non-conserved regions (as 
negative control). 
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Figure 4.4 Multi-species sequence analysis using ungapped transitive alignments 
(MUSSA) between  ceh-13/lin-39 Hox gene clusters in C. elegans and 
S. carpocapsae 
Alignment between lin-39 (red) and ceh-13 (orange) intergenic region in C. elegans and S. 
carpocapsae at a threshold of 23 conserved nucleotides out of 30 consecutive nucleotides.  Long 
intergenic noncoding RNA linc-57 (purple) in C. elegans is shown in purple, as well as the 
locations of known enhancers (N3, N9, I8, N10, and N11). Multiple predicted protein coding 
genes are shown in blue and dark blue in S. carpocapsae. Red lines in MUSSA analysis (Kuntz 
et al. 2008) indicate sense alignment between sequences. Blue lines indicate reverse 
complement alignment between sequences. 
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Preliminary Results 
S. carpocapsae IJs were collected (see Materials and Methods) and frozen at -
80°C, yielding enough material (roughly 12 mL of packed IJs, with around 3-4 mL 
packed IJs or 1.5 million worms in each experiment) for three to four DNase-seq 
biological replicates. One biological replicate (Replicate 1) has been treated with 
DNaseI and fully processed to the point of being ready for sequencing library 
preparation, with three other biological replicates in progress. 
QPCR is performed using duplicate genomic DNA standards and absolute 
derivative measurement of Cp. Relative fold enrichment of regulatory regions was 
measured in samples by normalizing the observed concentration of each region by 
the mean of negative control regions (Neg1, Neg4, Neg7, Neg8, Neg 9A and B). 
QPCR verification was performed on Replicate 1 S. carpocapsae IJ DNase seq 
samples (Figure 4.5). The sample showing relatively consistent levels of higher 
regulatory enrichment is the one treated with 160U/mL DNase-seq, with a final yield 
of 290 ng when measured using Qubit. Regulatory enrichment is highest for 
subregion showing homology to the N10 enhancer of C. elegans, with enrichment 
also observed for regions with homology to N3, N7, and N11 enhancers of C. elegans 
lin-39/ceh-13 Hox genes. We do not observe regulatory enrichment for the two FAR 
genes in this sample. Regulatory enrichment as measured by QPCR is a proxy for the 
relative level of DNase hypersensitivity observed in the experiment and it is possible 
the region that we chose in the FAR promoter is not highly accessible, or that our 
  
153
negative control regions (which we presume are non-enhancers) are still 
relatively DNaseI-accessible. 
  
 
Figure 4.5. QPCR results from S. carpocapsae IJ Replicate 1 
QPCR analysis shows a maximum regulatory enrichment of around 1.5 fold for the 160U/mL DNaseI 
sample. The highest enrichment is seen for a subregion showing homology to the N10 enhancer of C. 
elegans. Similar levels of enrichment are seen for other conserved regions with homology to the N3, 
N7, and N11 enhancers. 
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   C h a p t e r 5  
Conclusions 
C. elegans and other nematodes provide a fertile system to investigate 
cis-regulatory control of gene expression during development and its evolution 
across different species. This is particularly true at present since recent methods are 
now making it possible to systematically interrogate cis-regulatory function across 
the entire genomes of nematodes. Methods to discover cis-regulatory modules 
(CRMs) have been developed to be higher throughput and also transcription factor 
(TF)-agnostic, allowing additional CRMs regulated by TFs beyond those that are 
well-known to be studied. At the same time, sequencing data is high resolution, 
allowing the pinpointing of sites of potential TF binding. These findings contribute 
to our understanding of C. elegans transcriptional regulation at a genome-wide level 
by providing a resource that maps the sites of action by TFs and cis-regulatory 
modules (CRMs) in the embryo and L1 arrest and in genes that are regulated during 
these stages of development. 
Even with recent work in this field, there is still room for improvement for TF 
discovery algorithms in DNase-seq data. One issue is that with current algorithms, 
lowering the statistical threshold for the identification of TF footprints in DNase-seq 
data does not eventually lead to all TF footprints from ChIP-seq data being found 
(Sung et al. 2014). That said, not all TF sites found in ChIP-seq are functional or 
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drive enhancer activity. It thus remains to be seen what the differences are 
between TF sites of a given factor that are able to be found by DNase-seq and ChIP-
seq. It is possible for example, that the capture of TF binding sites by DNase-seq and 
ChIP-seq reflects different kinetics of TF binding. The data from Sung et al. (2014) at 
least, seem to point in that direction, since within DNase-seq the depth of TF 
footprinting is correlated with the residence time of TFs to DNA. We also do not 
know exactly how DNase-seq and ATAC-seq compare in this respect. 
We also face some challenges in understanding the spatial representation of 
DNase-seq data that arises from performing the assays in a multicellular organism. 
There are varying abundances of tissue and cell types in the C. elegans embryo or L1 
larvae depending on developmental stage. One of the major issues that we face is 
attribution of DHS that we discover to their tissues of origin. We can, however, 
attempt to address some of these issues by considering that the cell lineage of C. 
elegans is invariant (Sulston et al. 1983). 
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Different C. elegans tissues arise from different founder cell lineages that are 
created as a result of asymmetric cell divisions in the early embryo (Figure 5.2; 
reviewed in Labouesse and Mango, 1999 and Maduro 2010). Neuronal tissue arises 
from cells within the AB lineage, muscle tissue arises from the MS, C and D cell 
lineages, pharyngeal tissue arises from AB and MS cell lineages, intestinal (also 
known as mid-gut) tissue arises from the E cell lineage and epidermal tissue arises 
 
Figure 5.1 Origin of major tissues in the cell lineage of the C. elegans embryo 
Figure adapted from Labouesse and Mango, 1999. 
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largely from the AB and C cell lineages (Figure 5.1). The germline is descended 
from the P4 cell. 
 
Embryos for our DNase-seq were collected from developmental stages that 
range from roughly 43-cell stage (this timepoint can also be described as the 2E 
stage, since there are two E or endodermal cells) and onwards. At the 43-cell stage, 
                                                 
6 http://www.wormguides.org/ 
 
Figure 5.2 Cells in the C. elegans embryo at the 43-cell stage 
Cell diagram was generated using WormGuides6. Cells are color-coded according to the 
major lineage group, with ABa in red, ABp in green, MS in blue, E in yellow, C in white, D 
in light gray, and P4 in dark grey. Embryo is shown with dorsal side up and ventral side 
down. Anterior is to the left and posterior to the right. 
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the C. elegans embryo has initiated gastrulation and contains four cells from the 
MS lineage, four cells from the C lineage, sixteen cells from the ABp lineage, sixteen 
cells from the ABa lineage, two cells from the E lineage, one cell from the D lineage, 
and one cell of the P4 lineage (Figure 5.2; WormGuides; Sulston et al. 1983). By 35o 
minutes (shortly before bean stage), cell divisions are complete and this later stage 
C. elegans embryo has close to 560 cells (Figure 5.3; Sulston et al. 1983). The L1 
larva has 558 cells upon hatching, of which most (389) cells come from the AB 
lineage (reviewed in Riddle et al. 1997). The large number of cells present in the L1 
may partially explain our lower numbers (around 16,000) of noncoding DHS  
detected in L1 arrest larvae compared to embryos (around 26,000), since there is 
more cell heterogeneity and DNase-seq signal coming from any particular cell is 
likely to be more diluted. 
Lineage-specific expression data has been generated for many important 
embryo differentiation genes by Murray et al. (2012), who used cell lineage tracing 
methods with fluorescent reporter genes to quantitatively measure expression in 
developing C. elegans embryos through the 350-cell stage. Many of these genes 
could be useful markers in our DNase-seq data to give a sense of how sensitive our 
method is, if we are able to detect DHS near these actively transcribed genes from 
different C. elegans lineages (Table 5.1). A few of these genes have known CRMs, 
such as elt-2 and hlh-1 (which we have discussed in Chapter 2), but others have not 
had their regulatory regions dissected.  
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Among the genes listed in Table 5.1 which I selected on the basis of lineage-
restricted expression observed in the Murray et al. 2012 study, all possess detectable 
noncoding DHS in upstream regions except for end-3, ges-1, tbx-35 and tbx-38. 
Those genes exclusively expressed in the E lineage (end-1, end-3, elt-2, elt-7, pgp-2, 
and ges-1) are a good test case to consider, since a single tissue, the intestine,  arises 
from the E blastomere and its TF regulatory cascade has been well-studied (reviewed 
                                                 
7 http://epic.gs.washington.edu/ 
Gene Lineages in which expressed 
elt-2 E 
elt-7 E 
end-1 E 
end-3 E 
ges-1 E 
hlh-1 C and MS 
lin-1 Mostly ABp 
lin-32 Mostly ABa 
nhr-69 C and E 
pal-1 C and D 
pgp-2 E 
ref-2 MS and ABa 
pha-4 E, select MS and ABa 
tbx-35 MS 
tbx-37 ABa 
tbx-38 ABa 
vab-7 C and ABa 
 
Table 5.1. Some C. elegans 
differentiation genes and cell 
lineages in which they are 
expressed in embryos before 
the 350-cell stage. 
Data summarized from EPIC 
(Expression Patterns in 
Caenorhabditis7; Murray et al. 
2012) 
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in McGhee et al. 2007 and also described later in Murray et al. 2012). The GATA 
TFs END-1 and END-3 are expressed in the E cell lineages of the early embryo to 
specify the endoderm (reviewed in McGhee, 2007). Studies by Zhu et al. (1997) and 
Baugh et al. (2005) have shown that transcription of end-1 and end-3 is transient, 
with transcripts detectable in 1E-stage but gone by the 8E-stage. However, data from 
the reporter gene analysis by Murray et al (2012) shows that large “promoters” from 
end-1 and end-3 are able to drive reporter gene expression at least until the 350-cell 
stage. The expression driven by the end-3 promoter is also weak. In our embryo 
DNase-seq data, we observe a noncoding DHS in upstream region of end-1, but not 
end-3. This suggests that at least this case for the E lineage we are able to detect 
activation of end-1 which is highly expressed, but not end-3 which is more weakly 
expressed. 
Transcription of the GATA factor ELT-2 is activated by END-1 and END-3, is 
expressed from the 2E-stage (reviewed in McGhee et al. 2007). ELT-2 is the 
predominant factor expressed in the intestine after early endoderm specification. 
The study by Murray et al. (2012) showed the upstream “promoter” of elt-2 strongly 
drives reporter expression in the E lineage at least until the 350-cell stage. As was 
discussed in detail in Chapter 2, we detect many of the noncoding DHS of elt-2 
which overlap ELT-2 binding sites that mediate elt-2 autoregulation. Another GATA 
factor which is partially redundant with ELT-2 to specify the intestine is ELT-7 
(reviewed in McGhee et al. 2007). The study by Murray et al. (2012) showed that the 
elt-7 upstream “promoter” drove strong reporter expression in E lineage at least until 
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350-cell stage, and we detect noncoding DHS near this gene in our embryo 
DNase-seq data. Around this time, an ABC transporter pgp-2 is also expressed in the 
E lineage starting from the 2E stage (Murray et al. 2012; Schroeder et al. 2007 ) and 
we are able to detect noncoding DHS upstream of the gene in embryo DNase-seq. 
 The intestinal differentiation gene, ges-1, is activated by ELT-2 and expressed 
in late embryogenesis, at around 250 minutes. Based on our embryo DNase-seq 
data, which does not show DHS for ges-1, it is possible that our developmental time 
window of embryo collection could be too early to detect any ges-1 DHS. Another 
possibility is that if our sampling did include embryos collected at this stage of 
development (which would be around the 200-cell stage), in terms of the number of 
cells, any signal from the E lineage would be diluted by the more proliferated AB 
lineages. Thus, using these genes as marker genes for developmental timing and 
assuming that the DHS do indeed reflect CRM activity at this time, we can conclude 
our DNase-seq signal and sample is sufficient to detect early endoderm and intestine 
genes in E lineages in the early stages of embryonic development, but the signal from 
promoter of later stage gene, ges-1, are not present 1) due to errors in detection 2) 
the embryos collected do not include this later stage of development, or 3) if there 
are some late-stage embryos included in the collection, the DNase-seq signal 
originating from in the E lineage is diluted because of the large number of AB lineage 
cells dominating these later stage embryos. 
We can also consider another tissue, such as the pharynx, which arises from 
AB and MS lineages. Specification of the pharynx tissues (including many muscle 
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cells) is dependent on PHA-4/FOXA and T-box transcription factors TBX-2, 
TBX-35, TBX-37, and TBX-38 (reviewed in Mango et al. 2007). Expression of the 
redundant pair of TFs TBX-37 and TBX-38 is initiated in the ABa lineage at the 24-
cell stage (Good et al. 2004). TBX-35 is expressed in the MS lineage (Murray et al. 
2012). I observe noncoding DHS upstream of tbx-37 in the embryo DNase-seq data 
but not near tbx-38 and tbx-35. One explanation could that tbx-37 is more highly 
expressed and in more total cells in the embryo; tbx-37 is both highly expressed in all 
of the ABa lineages, whereas tbx-38 expression is more restricted within the ABa 
lineage, mostly descendents of ABala, and tbx-35 is moderately expressed in the MS 
lineage which does not contain as many cells as the ABa lineage. That said, we were 
able to detect highly expressed intestinal genes in E lineage cells in the previous case, 
so the number of cells is probably not the only limiting factor -- it is possible that 
lower expression of the gene may also impact DHS detection. The organ selector 
gene PHA-4, which is required for pharynx development, is expressed beginning in 
the 4E-stage (50-100 cells; Horner et al. 1998). Its expression was detected in the E 
cell lineage and selected cells in the ABa and MS lineages by Murray et al. (2012). As 
was described in Chapter 2, we are able to detect several noncoding DHS for pha-4 
including sites of autoregulation.  
The remaining genes that I investigated from Table 5.1 all possessed 
upstream noncoding DHS in the embryo DNase-seq data: hlh-1 (bHLH TF specifying 
body wall muscle in the C and MS lineages), lin-1 (an Ets TF expressed in mostly 
ABp cell lineages), lin-32 (bHLH TF expressed in mostly ABa cell lineages), nhr-69 
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(NR2 family receptor expressed in C and E lineages), pal-1 (homeodomain TF 
expressed in C and D lineages and important for body wall muscle development), 
ref-2 (expressed in neural and hypodermal precursors in the MS and ABa lineages), 
and vab-7 (Homeodomain TF expressed in posterior tissues in cells of ABa and C 
lineages). I also looked at some genes in Murray et al. (2012) dataset with many 
fewer cells: mnm-2 (TF expressed in select descendants of ABa and ABp), nhr-67 
(ortholog of Drosophila and mammalian tailless that is expressed in select 
descendants of MS and ABp), and ttx-3 (LIM homeodomain TF expressed in select 
descendants of ABa and ABp) and these contained many noncoding DHS upstream 
or in the introns of genes, suggesting that we are able to detect putative CRMs near 
these lineage-restricted genes and that our embryonic timepoints. 
Thus far, our DNase-seq analyses have largely focused on CRMs that promote 
gene transcription such as enhancers and promoters, and our results have shown 
positive correlations between the number of DHS and gene expression levels. One 
explanation for this is the nature of eukaryotic gene regulation, which relies on a 
complex chromatin structure that acts as an intrinsic barrier to transcription. 
Eukaryotic gene regulation features a transcriptionally restrictive ground state, 
requiring context-specific activators to direct transcription (reviewed in Struhl 
1999), which is a fundamentally different gene regulatory logic than prokaryotic gene 
expression. Thus eukaryotic genomes might have a bias towards CRMs that function 
to activate transcription of genes. Of course, CRMs function by binding both 
activator and repressor TFs to drive expression in specific spatiotemporal patterns. 
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Transcriptional repression is thus just as important as activation to properly 
control the expression of genes (reviewed in Payankaulam et al. 2010). 
However, I think a subset of the noncoding DHS that we find may in fact 
harbor negative regulatory activity and could potentially act as silencers. Previous 
studies have shown that silencers are identifiable by DNaseI hypersensitivity assays, 
such as silencers of mouse interleukin 4 and CD4 genes (Siu et al. 1994; Ansel et al. 
2004) and a constitutive autonomous silencer element recently found in human 
erythroid K562 cells (Qi et al. 2015). There are a few cases in our data that suggest 
that negative regulation may be occurring. In the case of hlh-1, a noncoding DHS was 
detected in the first intron harbored binding sites for PHA-4/FOXA (see Chapter 2 
for details). We suspect that this may be a negative regulatory CRM or potential 
silencer of hlh-1 expression in the pharynx. PHA-4 is known to be able to work as 
activator or repressor in different gene loci. For example, while PHA-4 activates 
many genes to promote pharyngeal differentiation, it also acts to repress ectodermal 
cell fate in the pharynx (Kiefer et al. 2007). We also found embryo noncoding DHS 
overlapping homeodomain binding sites for MAB-18 and CEH-14 which prevent 
activation of dauer collagen col-43 by the promoter of sth-1 that drive expression in 
the spermatheca (see Chapter 2 for details). Unfortunately, the numbers of identified 
silencers is lower than that for enhancers, despite the fact that there is precedent for 
some sequences to act as either an enhancer or silencer depending on the context. 
One such example is the neuron-restrictive silencer element (NRSE), which can act 
as an enhancer in neuronal cells but as a silencer in non-neuronal cells (Bessis et al. 
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1997). With improved methods and approaches in the future, perhaps we will 
able to gain a better understanding of these negatively regulating or silencer 
elements. One could imagine, for example, a massively parallel reporter assay 
designed to test some of the DHS that we have found as silencer elements. 
But first, it is important to find what percentage of CRMs predicted by 
DNase-seq data are able to act as enhancers and drive transgene reporter activity. I 
believe that our experiments to perform massively parallel testing of ten thousand C. 
elegans enhancers will help answer that question. This proof-of-principle of DNase-
seq in nematodes also opens the door to asking similar questions of more distantly 
related nematodes with highly varied lifestyles and developmental biology. I think 
that the data from Steinernema carpocapsae will be valuable in beginning to 
address questions of conservation of cis-regulatory sequences in Steinernema. 
Other challenges remain, such as the need to identify cell-type specific 
enhancers from specific cell or tissue populations and robust and high throughput 
ways to directly detect the identity of specific TFs that bind enhancers and other cis-
regulatory sequences. The identification of many thousands of CRMs and TF binding 
sites acting at different developmental stages of C. elegans is only one step on the 
path towards trying to understand the detailed mechanisms of cis-regulation in 
nematodes. 
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   A p p e n d i x  I  
DNaseI-seq protocol for nematodes 
 
 
Protocol is adapted from Stam Lab (Thurman et al. 2012) for DNase-seq and INTACT 
protocol for C. elegans nuclei isolation (Florian Steiner) 
 
Make Stam lab Buffer A and Tris NPB the week of experiment 
Make 1x DNase digestion buffer on the day of experiment 
 
Stock Reagents: 
Unless otherwise noted, all buffers & stock solutions should be chilled to 4°C (on ice) prior 
to use. 
 
0.5M Spermine 
Dissolve 5 grams Spermine Free Base in 49.43mL final volume sterile dH20. 
Store in convenient aliquots at -20°C. 
 
0.5M Spermidine 
Dissolve 1 gram Spermidine Free Base in 13.77mL final volume sterile dH20. 
Store at 4°C. 
 
DNaseI 10X Digestion Buffer (per 50mL) 
Final concentration Stock concentration Amount used from stock 
60mM CaCl2 1M CaCl2 3mL 
750mM NaCl 5M NaCl 7.5mL 
 
Combine stock solutions and 39.5mL sterile dH20. 
Can be stored at room temperature up to 1 year. 
 
Stock DNaseI 
Solubilize on ice with no vortexing entire bottle of DNaseI Type II in following storage 
buffer at a final concentration of 10U/μL: 
20mM Tris-HCl, pH 7.6 
50mM NaCl 
2mM MgCl2 
2mM CaCl2 
1mM Dithioerythritol 
0.1 mg/mL Pefabloc SC 
50% Glycerol 
Store in 250 μL aliquots at -20°C. 
 
Stam Lab Buffer A (per Liter) 
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Final Concentration Stock concentration Amount used from stock 
Sterile MilliQ Water  918mL 
15mM Tris-HCl, pH 8.0 1M Tris-HCl, pH 8.0 15mL 
15mM NaCl 5M NaCl 3mL 
60mM KCl 1M KCl 60mL 
1mM EDTA, pH 8.0 0.5M EDTA, pH 8.0 2mL 
0.5mM EGTA, pH 8.0 0.5M EGTA, pH 8.0 1mL 
0.5mM Spermidine 0.5M Spermidine Free Base 1mL 
   
Combine indicated amounts of stock solutions and sterile dH2O to final volume of 1 L. 
Store at 4°C. Use within 1 week. 
 
1X DNaseI Digestion Buffer 
Make day of use. 
For 50mL: add 5mL 10X DNaseI Digestion Buffer to 45mL Buffer A. 
Allow to equilibrate to 37°C for 60 minutes prior to use. 
 
Stop Buffer (per Liter) 
Final concentration Stock concentration Amount used from stock 
50mM Tris-HCl, pH 8.0 1.0M Tris-HCl, pH 8.0 50mL 
100mM NaCl 5.0M NaCl 20mL 
0.10% SDS 10% SDS 10mL 
100mM EDTA, pH 8.0 0.5M EDTA, pH 8.0 200mL 
Molecular Biology Grade sterile H2O  720mL 
 
Combine stock solutions and add sterile dH2O to a final volume of 1 L. Dispense into 25mL 
aliquots and store at 4°C. (SDS will precipitate upon storage at 4°C but will go back into 
solution upon warming to 37°C). 
 
On day of use, add the following to a 25mL aliquot: 
50 μL 0.5M Spermidine Free Base (final concentration: 1mM) 
15 μL 0.5M Spermine Free Base (final concentration: 0.3mM) 
 
NPB (Nuclei Purification Buffer): 
10mM Tris pH7.5 
40mM NaCl 
90mM KCl 
2mM EDTA 
0.5mM EGTA 
0.5mM Spermidine – add right before using 
0.2mM Spermine – easily oxidized, add right before using 
0.2mM DTT – easily oxidized, add right before using 
0.1% Triton X-100 
Store 4C, use within one week 
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Nuclei Isolation: 
1. Grind worm pellets to fine powder under liquid nitrogen using liquid nitrogen cooled 
mortar and pestle 
2. Bring volume to 7 mL with NPB 
3. Pre-cool centrifuge to 4°C. All centrifugations should be done at 4°C. 
4. Transfer to Dounce homogenizer with pipet 
5. Homogenize with Dounce homogenizer 30 strokes with tight fitting pestle 
6. Spin at 0.1 x g to pellet debris 
7. Collect nuclei containing supernatant and pool in new 50 mL tube on ice. 
8. For each 3 mL of supernatant, prepare 3 mL Optiprep (Sigma) cushion at bottom of 
15mL tubes. Apply supernatant on top. 
9. Spin nuclei down on cushion at 1000 x g 
10. Collect nuclei in a 15mL conical tube, these are input nuclei 
11. Proceed immediate to DNaseI treatment. 
Before DNaseI treatment, stain with DAPI and visualize using 100X lens on DIC. Use 
DAPI filter cartridge. Start with 20X magnification, using visual spectrum light, 
focus. Focus and close condenser to fine point on debris, then switch to higher 
magnification 100X using oil and open UV light source. 
 
DNaseI Treatment of Nuclei 
 
Work quickly using reagents maintained at appropriate temperatures. 
 
1. Pre-cool centrifuge to 4°C. All centrifugations should be done at 4°C. 
2. Add protease inhibitor tablet to Stam Lab Buffer A (1 tablet per 50mL solution) and 
solubilize. Keep on ice. 
3. Prepare fresh 1X DNaseI Digestion Buffer (Dilute 10X DNaseI Digestion Buffer 1:9 
with Stam Lab Buffer A). 
4. Warm Stop Buffer and 1X DNaseI Digestion Buffer (minus DNaseI) in 37°C 
temperature bath. Allow solutions to equilibrate for 60 minutes prior to use. 
5. Aliquot into equal volume tubes for DNaseI treatment. 
6. Centrifuge for 5 minutes at 500 x g at 4°C. Remove supernatant from all nuclei pellets. 
7. Add spermine free base and spermidine free base to Stop Buffer. (If SDS has 
precipitated out of solution, warm to 37°C to resuspend SDS prior to adding 
supplements). 
8. Aliquot 1X DNaseI Digestion Buffer: In 15mL conical tubes, 1-5mL 1X DNaseI 
Digestion Buffer (1mL per 10 million expected nuclei); number of tubes is determined 
by number of DNaseI treatments to be done. 
9. Just prior to starting DNaseI reaction with the nuclei pellet, add 5 μL Proteinase K 
per mL Stop Buffer. 
10. Also just prior to starting DNaseI I reaction with the nuclei pellet, add the 
appropriate amount of DNaseI enzyme to the 1X DNaseI Digestion Buffer 
aliquot. Mix thoroughly but gently by pipeting (DO NOT VORTEX) as the enzyme 
denatures easily with aeration. 
For 10 U/mL digestion, add 4 μL of 10U/μL stock DNaseI to 4mL of 1X DNaseI 
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Digestion Buffer. 
For 20 U/mL digestion, add 8 μL of 10U/μL stock DNaseI to 4mL of 1X DNaseI 
Digestion Buffer 
For 40 U/mL digestion, add 16μL of 10U/μL stock DNaseI to 4mL of 1X DNaseI 
Digestion Buffer 
 
Remaining steps should be timed carefully: 
1. Gently tap nuclei pellets a few times on the side of the ice bucket to loosen. Place tubes 
with loose nuclei pellets in 37°C temperature bath and allow the temperature to 
equilibrate for 1 minute. 
2. Gently resuspend nuclei with 1X DNaseI Digestion Buffer plus enzyme. 
3. Pipet several times gently using wide-bore tips to ensure homogenous suspension. 
4. Incubate for 3 minutes at 37°C in temperature bath. 
5. Add equal volume of Stop Buffer to DNaseI reaction tube and mix by inverting tube 
several times. 
6. Digest sample overnight in the 55°C temperature bath. 
7. Store treated samples at 4°C. 
8. Prior to gel electrophoresis and QPCR, incubate the samples at 37°C for 30 minutes 
with 1.5 μL 30 mg/mL RNaseA per mL of DNase-seq sample. 
9. Proceed to DNA purification, gel extraction, Qubit and PCR. 
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A p p e n d i x  I I  
Supplementary Information for Chapter 2 
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Appendix Table 2.1. Sequenced DNase-seq samples. 
A. Sample yield and regulatory enrichment by QPCR. Four biological replicates of 
embryo (A-D) and five of L1 arrest (V-Z) DNase-seq were performed. The DNA yield of 
each sample was measured using Qubit fluorescence. The DNaseI treatment level that 
exhibited the highest fold QPCR regulatory enrichment (comparing lin-39/ceh-13 Hox 
conserved enhancer regions vs. non-enhancer sequences from Kuntz et al. 2008; see 
Methods) was sequenced. B. Read mapping to C. elegans genome with Bowtie 
1.0.0. Reads were mapped to the ce10/WS220 genome and alignment statistics reported 
by Bowtie are shown for each biological replicate: Number of 1) Reads processed by Bowtie 
after Q20 filtering and trimming (Reads Processed) 2) Reads with at least one reported 
alignment 3) Reads that failed to align 4) Reads with alignments suppressed due to multi-
mapping to more than two unique genomic locations.  Percentages are shown in 
parentheses. Uniquely mapping reads ranged between 38% and 76% in these samples 
result in slightly above 15X coverage in each sample. Out of four embryo samples, 
replicates A-C showed more ideal alignment statistics, reflecting DNA yield of biological 
replicates in (A). 
Reads
Processed
(Q20 ﬁlter+trim)
Reads with at
least one reported
alignment 
Reads that
failed to align
Reads w/ alignments
suppressed due to
multimapping
18,523,832
38,482,313
7096637 (38%) 10334476 (56%) 1092719 (5.9%)
24084424 (63%) 1021020 (2.7%) 13376869 (35%)
21,165,105 16086392 (76%) 657736 (3.1%) 4420977 (21%)
39,673,047 28040916 (71%) 6059497 (15%) 5572634 (14.%)
Appendix Table 2.1. Sequenced DNA samples
B. Read mapping to C. elegans genome (ce10/WS220) with Bowtie 1.0.0
Flowcell
Sample ID DNA yield
Highest Fold enrichment
vs. bkgrd (N5, N6)
DNaseI treatment level
w/ most enrichment
Strain & Stage
A. Sample yield and regulatory enrichment by QPCR
Replicate
ID
Strain & Stage
N2 Embryo
N2 Embryo
N2 Embryo
N2 Embryo
13577
13578
13583
14140
Flowcell
Sample ID
160 U/mL 3 ng5.313577 N2 EmbryoD
120 U/mLN2 Embryo 39 ng3.913578C
80 U/mLN2 Embryo13583 50 ng6.3B
160 U/mLN2 Embryo14140 19 ng6.4A
Replicate
ID
D
C
B
A
14138 N2 L1 arrestW
N2 L1 arrest13582X
N2 L1 arrest13579Y
N2 L1 arrest13576Z
V 14139 N2 L1 arrest
80 U/mL
20 U/mL
160 U/mL
80 U/mL
160 U/mL
336 ng
8ng
17ng
27ng
25ng5.7
1.4
5.5
5.8
4.7
W
X
Y
Z
N2 L1 arrestV
N2 L1 arrest
N2 L1 arrest
N2 L1 arrest
N2 L1 arrest14138
13582
13579
13576
14139
42,554,211
16,074,836 
11,397,805 
24045456 (57%) 863912 (2.0%) 17644843 (41%) 
10010938 (62%) 1491568 (9.3%) 4572330 (28%) 
7679786 (67%) 699720 (6.1%) 3018299 (26%) 
30,376,192 20166440 (66%) 3950146 (13%) 6259606 (21%) 
32,487,179 15981175 (49%) 12066750 (37%) 4439254 (14%) 
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Appendix Table 2.2. QPCR validation 
QPCR primers were designed to amplify MUSSA conserved regions from “true positive” 
enhancers of the lin-39/ceh-13 Hox genes (Kuntz et al. 2008), conserved regions from the 
enh2 and enh4 enhancers of hlh-1, and  intergenic and promoter regions of unc-54, ceh-22, 
let-70, and cct-8 genes. QPCR primers were also designed to amplify subregions of negative 
control non-enhancer sequences, N5 and N6, previously described by Kuntz et al. (2008). 
Appendix Table 2.2. QPCR primers and amplicons used to measure regulatory enrichment
Forward Primer Reverse PrimerQPCR RegionLabel
Amplicon Coordinates
(ce10/WS220)
Corresponds to
Regulatory Region
CAAAGTGCACAATGCTGTCC
SK_N2_1
CCGCAGCGGTATCTCTCTTA N1SK_N1_2 chrIII:7,531,492-7,531,564
TTGGGCTTGAAGTGGTTAGG GTCGCGAGCCCATTTATCT chrIII:7,532,042-7,532,129 N2
SK-N2_3 TCGCCTTCTTCCTTATGCTTC AGGAAGCTACAGTACTCCCCTTCT chrIII:7,532,219-7,532,291 N2
GAGACAAACAGCGGGAACAA CGCAGTGAGGGAAAATGAAASK-N3_1 chrIII:7,533,122-7,533,211 N3
SK-N4_2
SK-N5_1
SK-N5_3
CCTTAACGCGACCAAGGTTA ACTCCAAAATTGGCCCAAAA
GGTCTTCCAATCTAGTGCAAACA TCCCTCTTTTTCTCGTCATTTG
SK-N6-1 ACGCCTTTCGAGAAGTCTATTGT AATTTGTTGCAGGCCACATC
SK-N7-1 AATGGCACCCATAAATCTCAAC TCTCATCCTCTTCCTCTCTCCA
SK-N8-2 TGCCAAGGATCTAGAGGGTGT CAATCCGACAACACCAATCA
GATGGACATGGGGTGAGAAC CGGCAACTTAAAAGCGAAAA N4
N5 (negative ctrl)
SK-N9_1
SK-N9_2
TACAAGCCCACGACCATTCT CCACAGAGAGACATGGGAACA
CGGTGCATTTTGGAAGAAGT TCGGAACAGTTGGTAAGTTGC
SK_N11-1 CTCCTTCTTTTCCCCGTGTC GAGAGAGACACCATCCGATCA
N5 (negative ctrl)
N6 (negative ctrl)
N7
N8
N9
N9
N11
chrIII:7536786-7536879
chrIII:7,548,980-7,549,053
chrIII:7,549,080-7,549,153
chrIII:7,554,774-7,554,850
chrIII:7,544,309-7,544,395
chrIII:7,543,275-7,543,364
chrIII:7,545,257-7,545,329
chrIII:7,538,661-7,538,735
chrIII:7,538,116-7,538,200
ceh-22
unc-54
let-70
cct-8
hlh-1_enh2
hlh-1_enh4
TAAAGCTGTGTGCGGCAGCGGCA ACTACGCGTAGGCGTCTCTCGC unc-54 upstreamchrI:14,863,598-14,863,685
AAAATGAGCGACGGGGTGAG GTACCCTCTTACGTTTCCTGTGTT chrIV:11,082,900-11,082,975 let-70/klc-1
GAGATGTGGGGTACGGTGGA ATGACACCGAACTTGACGCG chrIV:1,094,354-1,094,416 cct-8 upstream
CGGTTGTCAATTGCACTCGAG GATAGAAGGCGTCGCTGCTG chrV:10,672,580-10,672,654 ceh-22 distal promoter
GCCTCCATCAACGTCTTAACGGC CTCTCTTGCTTCCCGAGAAGCTACC chrII:4,520,326-4,520,394
AAGGTGTCGGTTGTAGCAGC AGAGTTGAGCCGAGAGTTGC chrII:4,517,444-4,517,507 hlh-1 enhancer 2
hlh-1 enhancer 4
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Appendix Table 2.3. Predicted novel regulatory motifs 
Novel regulatory motifs (shown in IUPAC and logos) were predicted as well as the Gene 
Ontology and anatomy enrichment of motif-associated genes. Motifs were predicted by 
DREME in different categories of noncoding DHS (left border). P-values (p-val) and 
erased E-value (E-val) are shown. In many cases, motifs matched a previously identified 
Stormo or Elemento motif (Ihuegbu et al. 2012; Elemento et al. 2005; Prior Match?). 
Motif-associated genes were selected by FIMO using a P-value cutoff (Threshold) to 
identify the presence of motifs within noncoding DHS. Number of motif-associated genes 
(#Genes) used in the analysis of GO enrichment using AmiGO is shown. Top enriched GO 
terms are shown (Gene Ontology Enrichment) and related GO terms were highlighted 
(blue background). If present, enriched anatomy terms (Anatomy Enrichment) are also 
shown. 
Novel Intergenic motifs
0
1
2
bi
ts
1A 2C 3T 4A 5C 6A 7A 8A 9C 10T 11A 12C
0
1
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ts
1A 2G 3C 4G 5AG 6A 7G 8G 9A 10C 11G 12A
0
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2
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ts
1
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2T 3CT 4C 5A 6G 7C 8T 9C 10C
0
1
2
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ts
1C 2T 3T 4G 5T 6A 7C 8G 9G 10A 11A
Appendix Table 2.3.
0
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ts
1G 2G 3T 4C 5T 6C 7G 8C 9C 10GA 11C
0
1
2
bi
ts
1G 2TA 3A 4C 5T 6T 7T 8T 9G 10A 11A
0
1
2
bi
ts
1T 2A 3T 4T 5T 6TC 7A 8A 9A 10A 11A
response to chemical stimulus
steroid hormone mediated signaling
response to Ca2+ ion
organic substance metabolism
dauer entry 
regulation of cellular metabolism
phosphorus metabolism
phosphate metabolism
purine ribonucleotide catabolism
anatomical structure development
ion membrane transport
actin myosin ﬁlament sliding
signal transduction
cell response to stimulus
signaling
cell communication
activation of RasGTPase activity
IUPAC Motif Motif Logop-val E-val
Prior
Match? #Threshold Gene Ontology Enrichment
AAAATCATATG 1.50E-08 0.029 None 190.05
peptidyl amino acid modiﬁcation
actin ﬁlament based movement
G protein-coupled acetylcholine receptor pathway
ACTACAAACTAC
AGCGRAGGACGA
3.70E-09 0.0073 0.025 24
2.30E-10 0.00045 None 0.025 39
CTTGTACGGAA 1.50E-08 0.029 None 0.05 18
CTYCAGCTCC 2.50E-09 0.0049 None 0.05 27
establishment of localization
ion transport
vesicle mediated transport
transmembrane transport
signaling
synaptic transmission
cell-cell signaling
cell communication
nucleobase-containing compound metabolism
cellular macromolecule biosynthesis
heterocyclic metabolism
GGTCTCGCCRC 6.30E-18 1.30E-11 None 0.025 63
GWACTTTTGAA
phosphorylation
protein phosphorylation
phosphate containing compound metabolism
phosphorus metabolism
peptidyl threonine phosphorylation
cell fate commitment
7.20E-06 7.20E-06 None 0.05 8
TATTTYAAAAA 4.00E-04 8.70E-02 None 0.05 12
A
Predicted functions for novel regulatory motifs
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1A 2A 3A 4A 5T 6T 7C 8CA 9A 10A 11AAAAATTCMAAA response to chemical stimuluscellular metabolism1.10E-08 0.022 0.05 77StormoF01D5.10.8
Stormo
C39D10.7.2
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Anatomy
Enrichment
head neurons
seam cell
spermatheca
excretory cell
tail neurons
head neurons
coelomocyte
pharyngeal muscle
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reproduction
organ development
reproductive structure development
developmental process involved in reproduction
aging
nucleobase-containing compound metabolism
IUPAC Motif p-val E-val
Prior
Match? #Threshold Gene Ontology Enrichment
CGCGACGCR 7.50E-13 9.10E-07 None 0.05 50
cellular metabolism
translation
cellular protein metabolism
cellular macromolecule biosynthesis
protein metabolism
cellular macromolecule metabolism
gene expression
embryo development
cellular localization
transport
transport
establishment of localization
macromolecule localization
maintenance of location
lipid localization 
localization
lipid storage
regulation of biological quality
vesicle mediated transport
membrane organization
3.60E-09 0.0043 None 0.05 34
GCRGCCGACA 1.10E-10 0.00013 None 0.05 33
AGGYAGGCR
CGTAAATCKAC
CCCCCCCYCCC
5.10E-24 6.50E-18 None 0.05 67 establishment of localizationdevelopmental process
cellular macromolecule metabolism
small molecule metabolism
organic substance metabolism
nitrogen compound metabolism
phosphate-containing compound metabolism
establishment of localization
transport
3.90E-16 4.90E-10 Stormo
6R55.1a.3
0.025 129
B
Anatomy
Enrichment
pharynx
tail
vulva
head
tail
spermatheca
intestine
vulval muscle
BWM
anal dep. muscle
nerve ring
tail neurons
Motif Logo
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Novel Intron motifs
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cellular component organization or biogenesis
regulation of signal transduction
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cellular response to stimulus
signal transduction
regulation of response to stimulus 
signaling
cell communication
response to stimulus
metabolism
protein metabolism
organic substance metabolism
catabolism
regulation of metabolism
establishment of localization
RNA splicing
IUPAC Motif p-val E-val
Prior
Match? #Threshold Gene Ontology Enrichment
AATTTGAATTTY
ACCGCRMCGC
1.50E-15 2.80E-09 None 0.025 53
1.40E-28 2.70E-22 None 0.025 71
transport
establishment of localization
endocytosis
receptor-mediated-endocytosis
vesicle mediated transport
localization
embryo development
heterocycle metabolism
ACTACAAAMT 3.00E-53 6.30E-47  StormoC39D10.7.2 0.025 123
CAAATTTTSA 1.50E-08
establishment of localization
transport
receptor-mediated endocytosis
reproduction
0.027 None 0.05 70
cellular macromolecule metabolism
protein metabolism
organic substance metabolism
macromolecule metabolism
cellular component organization or biogenesis
C
CCMCGCCCAC 9.50E-09 0.017 None 0.05 56
RNA metabolism
cellular nitrogen compound metabolism
nucleobase-containing compound metabolism
cellular protein metabolism
cellular macromolecule metabolism
protein metabolism
gene expression
nitrogen compound metabolism
carboxylic acid metabolism
small molecule metabolism
organic acid metabolism
establishment of localization
transport
CGYGGCGAGAC 2.00E-32 4.00E-26 None 0.025
GAAGCTATGC
glucose transport
positive regulation of barrier septum assembly
chemical homeostasis
3.40E-15 6.50E-09 None 0.05
GCTGCTGCY 2.00E-19 4.00E-13
Elemento
Motif 151 0.05 93
GCVGCCGAC 3.70E-41 7.60E-35 None 0.05 165 response to stimulus
TGCGCCTTTAA 1.50E-08 0.027 None 0.025 25
Anatomy
Enrichment
ventral cord neurons
tail
tail neurons
nerve ring
head neurons
coelomocyte
germline
ventral cord neurons
ventral nerve cord
dorsal nerve cord
nerve ring
Motif Logo
tail neurons
BWM
anal dep. muscle
head neurons
hypodermis
vulval muscle
BWM
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nucleobase-containing compound metabolism
cellular nitrogen compound metabolism
cellular aromatic compound metabolism
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reproduction
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0.025
cellular amino acid metabolism
regulation of actin cytoskeleton organization
glutamine family amino acid metabolism
nematode larval development
post embryonic development 
post-embryonic organ development
cellular protein metabolism
protein metabolism
ncRNA processing
apoptotic cell clearance
mitoch. respiratory chain complex I biogenesis
mitoch. respiratory chain complex I assembly
NADH dehydrogenase complex assembly
IUPAC Motif Motif Logop-val E-val PriorMatch? #Threshold Gene Ontology Enrichment
D
AAATGGGCGTA 7.40E-09 0.024 None 0.05 29
AAATTKGAATTC
ribosome biogenesis
cellular component biogenesis
rRNA metabolism
protein metabolism
cellular macromolecule metabolism
cellular protein metabolism
protein glycosylation
glycosylation
organic substance metabolism
ion transport
transmembrane transport
metal ion transport
ion transmembrane transport
3.70E-11 0.00012 None 0.025 48
ACAGAACCGTGG
cellular component organization
apoptotic process
cellular component organization or biogenesis
aging
anatomical structure development
reproduction
4.60E-10 0.0015 F45F2.11.3
Stormo
0.025 32
positive regulation of biological process
regulation of biological process
regulation of multicellular organismal process
reproduction
vesicle-mediated transport
transport
endocytosis
RNA metabolism
RNA processing
nucleic acid metabolism
cellular macromolecule metabolism
gene expression
AGCAGCGYCCA 7.20E-31 2.50E-24 None 0.025 54
biological procellular metabolism
phosphorus metabolism
phosphate-containing compound metabolismATGGTGCATYG 1.10E-13 3.70E-07 None 0.05 39
reproductionCAACGATGCTC 4.60E-10 0.0015  StormoF55A3.1.4 0.05
CCACGCAGGY 5.80E-11 0.00019
phosphate-containing compound metabolism
phosphorylation
dephosphorylation
phosphorus metabolism
cellular protein metabolism
cellular macromolecule metabolism
protein metabolism
insulin receptor signaling pathway
dauer larval development
determination of adult lifespan
aging
dauer entry
None 0.05
CCACTGMGCCA
CCCARTTGGACA
CCGGWCGTCCG
cellular metabolism
cell communication
cellular response to stimulus
3.60E-12 570.025None0.000012
2.20E-13 7.30E-07
cell death
death
reproduction
cell metabolism
None 40
2.90E-11 0.000094 None 0.025 32
CCTSTAGCGCG 9.20E-10 0.003 None 0.05 18
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germline
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ventral cord neurons
coelomocyte
germline
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CCTYGTGATCC
anatomical structure development
embryo development
post-embryonic development
nematode larval development
reproduction
genitalia development
establishment of localization
transport
receptor-mediated endocytosis
1.80E-09 0.0059 None 0.05
anatomical structure development
embryo development
post-embryonic development
nematode larval development
embryo devt ending in birth or egg hatching
genitalia development
developmental process involved in reproduction
reproduction
CGAAGGATCAC 7.20E-11 0.00023 None 36
IUPAC Motif Motif Logop-val E-val
Prior
Match? #Threshold Gene Ontology Enrichment
CGCGCAAATGA
localization
embryo development
embryo devt ending in birth or egg hatching
glycoprotein metabolism
protein glycosylation
7.40E-09 0.024 Elemento
Motif 95
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signal transduction
cellular response to stimulus
regulation of cellular process
regulation of biological process
response to chemical stimulus
response to stimulus
signalling
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establishment of localization
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macromolecule localization
vesicle-mediated transport
cell communication
organic substance metabolism
cellular nitrogen compound metabolism
cellular metabolism
macromolecule metabolism
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W04C9.6.7
0.05 190
CGTGGYGAGAC
cellular protein metabolism
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nucleobase-containing compound metabolism
cellular aromatic compound metabolism
macromolecule metabolism
biosynthesis
transport
receptor-mediated endocytosis
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ion transport
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molting cycle
molting cycle, collagen, and cuticulin-based cuticle
genitalia development
hermaphrodite genitalia development
3.60E-12 0.000012 None 29
GAATTGCGYCA
phosphate-containing compound metabolism
dephosphorylation
peptidyl-tyrosine dephosphorylation
phosphorus metabolism
cellular metabolism
310.05None0.00023
regulation of biological process
cellular process
response to stimulus
biological regulation
GCRGCCGACA 8.90E-59 3.20E-52 None 0.025
nerve ring
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germline
tail
dorsal nerve cord
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RNA metabolism
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gene expression
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nitrogen compound metabolism
cellular amino acid metabolism
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metabolism
organic substance metabolism
organophosphate metabolism
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ATP synthesis coupled proton transport
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regulation of signal transduction -->
positive regulation of response to stimulus
positive regulation of cellular process
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regulation of signalling
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regulation of response to stimulus
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organic substance metabolism
cellular metabolism 0.16.40E-07 8.90E-08 None
organic substance metabolism
macromolecule metabolism
primary metabolism
localization
DCTCCGCC 2.60E-09 1.90E-09 None 0.1
phosphate-containing compound metabolism
organic substance metabolism
nitrogen compound metabolism
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Appendix Table 2.4. DNase-seq data files  
List of data files and sequence tracks to be made available for download and viewing 
through WormBase. Read data will be deposited in the NCBI Short Read Archive (SRA). 
Appendix Table 2.4. DNaseI-seq data ﬁles
Filetype Description
BigWig Merged Embryo DNaseI signal (total)
BigWig
Merged Embryo DNaseI signal (positive strand)
BigWig
Merged Embryo DNaseI signal (negative strand)
BED All DHS (post-IDR, ﬁltered)
BED
Noncoding DHS + gene annotation
BED Embryo TF Footprints
TXT Novel motifs (in MEME format)
TXT
Enriched Gene Ontology and anatomy terms for each motif
List of motif-associated genes for each motif
TXT
BigWig
Embryo DNaseI signal (total) for each replicate A, B, C, D
BigWig
Embryo DNaseI signal (positive strand) for each replicate A, B, C, D
BigWig
Embryo DNaseI signal (negative strand) for each replicate A, B, C, D
merged.embryo.ce10.negative.bw
merged.embryo.ce10.positive.bw
merged.embryo.ce10.total.bw
File Name
merged.embryo.ce10.A.total.bw
merged.embryo.ce10.B.total.bw
merged.embryo.ce10.C.total.bw
merged.embryo.ce10.D.total.bw
merged.embryo.ce10.A.positive.bw
merged.embryo.ce10.B.positive.bw
merged.embryo.ce10.C.positive.bw
merged.embryo.ce10.D.positive.bw
merged.embryo.ce10.A.negative.bw
merged.embryo.ce10.B.negative.bw
merged.embryo.ce10.C.negative.bw
merged.embryo.ce10.D.negative.bw
embryo.ce10.allDHS.bed
embryo.ce10.noncodingDHS.bed
embryo.ce10.noncodingDHS_geneannot.txt
embryo.ce10.DHSfootprints.FDR0.05.bed
embryo.DNaseI.novelmotifs.txt
embryo.DNaseI.motifassocgenes.txt
embryo.DNaseI.motifGO.txt
embryo.DNaseI.motifanatomy.txt
BigWig Merged L1 DNaseI signal (total)
BigWig
Merged L1 DNaseI signal (positive strand)
BigWig
Merged L1 DNaseI signal (negative strand)
BED All DHS (post-IDR, ﬁltered)
BED
Noncoding DHS + gene annotation
BED L1 Arrest TF Footprints
BigWig
L1 DNaseI signal (total) for each replicate Z, Y, X, W, V
BigWig
L1 DNaseI signal (positive strand) for each replicate Z, Y, X, W, V
BigWig
L1 DNaseI signal (negative strand) for each replicate Z, Y, X, W, V
merged.L1.ce10.negative.normalized.bw
merged.L1.ce10.positive.normalized.bw
merged.L1.ce10.total.normalized.bw
merged.L1.ce10.Z.total.bw
merged.L1.ce10.Y.total.bw
merged.L1.ce10.X.total.bw
merged.L1.ce10.W.total.bw
merged.L1.ce10.Z.positive.bw
merged.L1.ce10.Y.positive.bw
merged.L1.ce10.X.positive.bw
merged.L1.ce10.W.positive.bw
merged.L1.ce10.Z.negative.bw
merged.L1.ce10.Y.negative.bw
merged.L1.ce10.X.negative.bw
merged.L1.ce10.W.negative.bw
L1.ce10.allDHS.bed
L1.ce10.noncodingDHS.bed
L1.ce10.noncodingDHS_geneannot.txt
L1.ce10.DHSfootprints.FDR0.05.bed
merged.L1.ce10.V.total.bw
merged.L1.ce10.V.positive.bw
merged.L1.ce10.V.negative.bw
L1 arrest-speciﬁc noncoding DHS + gene annotation
BED L1arrestspeciﬁc_noncodingDHS.bed
TXT L1arrestspeciﬁc_ncDHS_annot.txt
TXT
TXT
188
189 
 
Appendix Figure 2.1. Additional known and novel enhancer CRMs 
(A) I8 (“False Negative” in the Kuntz et al. study) detected, as well as N10 and 
N11 enhancers of ceh-13. A noncoding DHS containing TF footprints is detected in an 
evolutionarily conserved part of I8 region (reported as “false negative” in Kuntz et al. 
2008) able to drive reporter expression. A second noncoding DHS containing TF 
footprints is also detected in the known highly conserved N10 enhancer. A third noncoding 
DHS harbors a TF footprint that overlaps with N11 enhancer and conserved MUSSA sub-
region. Three other noncoding DHS containing TF footprints are detected in conserved 
regions downstream of ceh-13 and in its first intron. These noncoding DHS are in regions 
of the lin-39/ceh-13 Hox cluster not tested in the Kuntz et al. (2008) study but which are 
transcribed in embryos (Chen et al. 2013). 
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(B) Embryo noncoding DHS and footprints recapitulate known myo-3 
enhancers in 5’ region and first intron. Two embryo noncoding DHS containing TF 
footprints are detected in 2kb region upstream of myo-3 and overlap with MC197 and 
MC165 enhancers (purple). Another noncoding DHS is detected in the first intron which 
also harbors TF footprints and overlaps with MC186 enhancer (purple) and three ncRNA 
transcripts K12F2.5, K12F2.4, and K12F2.3. These noncoding DHS overlap with multiple 
TSS and MULTIZ conserved elements. 
  
ch
rV
:
El
em
en
ts
Re
pe
at
M
as
ke
r
2 
kb
ce
10
12
,2
27
,0
00
12
,2
28
,0
00
12
,2
29
,0
00
12
,2
30
,0
00
12
,2
31
,0
00
12
,2
32
,0
00
12
,2
33
,0
00
12
,2
34
,0
00
12
,2
35
,0
00
12
,2
36
,0
00
m
yo
-3
K1
2F
2.
5
K1
2F
2.
4
K1
2F
2.
3
12
1 
- 
1 10
4 
- 
1 10
4 
- 
1 
H3
K4
m
e3
em
br
yo
N
on
co
di
ng
 D
HS TS
S
RN
AP
II 
ea
rly
 e
m
br
yo
CB
P-
1 
em
br
yo
HO
Tc
or
e
N
on
co
di
ng
 F
oo
tp
rin
ts
To
ta
l D
N
as
eI
 si
gn
al
M
C1
86
M
C1
97
M
C1
65
m
yo
-3
 e
nh
an
ce
rs
O
kk
em
a 
et
 a
l.,
 1
99
3)
Ap
pe
nd
ix
 F
ig
ur
e 
2.
1B
Po
si
ti
ve
 S
tr
an
d 
D
N
as
eI
 s
ig
na
l
N
eg
ati
ve
 S
tr
an
d 
D
N
as
eI
 s
ig
na
l
Co
ns
er
va
ti
on
Al
l D
HS
Pr
ev
io
us
DN
as
e-
se
q
m
od
EN
CO
DE
192
193 
 
(C) Two known enhancers of hlh-1 detected and additional intronic PHA-4 
binding site. Three noncoding DHS harboring TF footprints are detected in 3kb region 
upstream of hlh-1, including the promoter, two of which overlap with known enh1 and 
enh2 enhancers (purple).  These noncoding DHS overlap with conserved MULTIZ 
elements and marks of enhancer activity, such as RNAPII, CBP-1, TSS, and H3K4me3. 
Another noncoding DHS is detected in the first intron, and contains TF footprints which 
may correspond to regions of PHA-4 binding (Zhong et al. 2010).  
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(D) Embryo noncoding DHS detected between col-43 and sth-1 and overlap 
with homeodomain binding sites required for enhancer-blocking. Two 
noncoding DHS (light blue) harboring TF footprints are detected in intergenic region 
between col-43 and sth-1. Of these, one overlaps with HB1 homeodomain site bound by 
MAB-18 and CEH-14 TFs as well as noncoding transcript ZC513.16 (Bando et al. 2005). 
Another overlaps with HB2 homeodomain site known to bind MAB-18 and a TSS (Chen et 
al. 2013). Homeodomain binding sites HB1 and HB2 shown in purple.  
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Appendix Figure 2.2. Regulatory enrichment by QPCR 
QPCR was performed on DNaseI-treated DNA using primers designed to amplify 
conserved parts of known enhancers and negative control regions N5, N6 (see Methods 
and Table S2). Fold enrichment is measured by normalizing measured QPCR 
concentration by the average concentration of negative control regions. A range of DNaseI 
concentrations from 0 (red), 10 (orange), 20 (magenta), 40(yellow), 80 (green), 120 (blue), 
and 160 (purple) U/mL were used to treat each sample. The sample with DNaseI 
concentration exhibiting the highest relative fold regulatory enrichment was sequenced. In 
the cases of embryo replicates A-C, these were 160 U/mL, 80 U/mL, and 120 U/mL, 
respectively. In the cases of L1 arrest replicates X-Z, these were 80 U/mL, 20 U/mL, 160 
U/mL, 80 U/mL and 160 U/mL, respectively. 
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Appendix Figure 2.3. Frequency of TF footprints, Noncoding DHS, and genes 
and motifs predicted from noncoding DHS for tissue-specific gene sets 
(A) Percentage of embryo noncoding DHS containing footprints for different 
promoter/enhancer-associated marks. The number of noncoding DHS that were 
observed with footprints (darker shading) or without footprints (lighter shading) are 
shown for each type of enhancer-associated mark: TSS (pink), H3K4me3 (emerald green), 
RNAPII (purple), CBP-1 (orange), HOT (blue) or All Marks (lime green), and for the 
noncoding DHS as a whole (red). (B) Number of embryo noncoding DHS per gene. 
Distribution of noncoding DHS overlapping near protein-coding genes shows that 53% 
(10,890) of protein-coding genes were assigned at least one embryo noncoding DHS 
nearby, according to annotation that assigned the nearest gene to each noncoding DHS. 
9822 (47%) of genes were not annotated with nearby embryo noncoding DHS. 17% (1,901) 
were annotated with more than four embryo noncoding DHS. (C) Known gut motifs 
identified. Two motifs identified in our analysis of overrepresented motifs in noncoding 
DHS of gut-expressed genes (genes identified in SAGE of dissected adult C. elegans 
intestine by McGhee et al. 2007) match known binding motifs of two gut TFs, SLR-2 and 
ELT-2. Shown are the motif comparisons between the identified motifs from DREME and 
the consensus motifs (Kirienko and Fay 2010; McGhee et al. 2009) and their associated p 
and q-value measured by TOMTOM. (D) Known neuronal motif identified. One 
motif identified in our analysis of overrepresented motifs in genes expressed in neurons 
(genes identified in SAGE of FACS-sorted neurons by Spencer et al. 2011) matches known 
binding motif of one neuronal TF, EGL-5. Shown is motif comparison between identified 
motif from DREME and consensus motif from Gerstein et al. (2010) and the associated p 
and q-value measured by TOMTOM.  
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Appendix Figure 2.4. Average DNaseI profile over C. elegans motif sites 
Known C. elegans regulatory motif sites show characteristic patterns of accessibility to 
DNaseI cleavage and demonstrate strand-shift in reads that is indicative of TF footprints. 
Average DNaseI profile is calculated over thousands of predicted motif sites within the 2 
kb upstream region of genes using the start sites of reads across 80bp region surrounding 
the motif. Positive strand is shown in red and negative strand is shown in green. Light blue 
indicates the base pair position of the motif site: EGL-5 (9bp), EGL-27 (8bp), N1 (10bp), 
SP1 (15bp), PHA-4 motifs 3 (10bp), 4, 11 (9bp), and NHR-6 (7bp). 
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Appendix Figure 2.5. L1 stage specific DHS are more highly expressed in L1 
arrest compared to the embryo and are found in genes that are targets of DAF-
16 and PHA-4 and whose expression is affected by starvation 
(A) Genomic location of L1 arrest DHS shows abundance of noncoding DHS. L1 
arrest DHS were annotated according to position relative to WormBase WS241 
protein‐coding genes: exons (blue) and noncoding (red). Noncoding DHS are further 
subdivided into introns (pink), promoter (defined as less than 300bp 5’ of ATG; yellow) and 
intergenic (orange) regions.  67% of L1 arrest DHS were annotated in noncoding regions, 
with 33% annotated in exons. Within L1 arrest noncoding DHS, 27%, 13%, and 28% were 
annotated in introns, promoters, and intergenic regions, respectively.  (B) L1 Arrest 
biological replicates show reproducibility of matched peaks. Comparison between 
number of common peaks and significant peaks in pairs of L1 arrest biological replicates 
when all raw peaks are assessed together (All Peaks) or peaks matching in replicates 
(Matched Peaks). Pairwise comparisons of L1 arrest biological replicates: A vs. Z vs. Y 
(black), Z vs. X (red), Z vs. W (purple), Z vs. V (green), Y vs. X (blue), Y vs. W (light blue), Y 
vs. V (violet), X vs. W (orange), X vs. V (grey), W vs. V (brown) are shown. (C) Observed 
relationship between irreproducible discovery rate (IDR) threshold and 
number of significant peaks called in biological replicates. 49,882 reproducible L1 
arrest DHS peaks remained after IDR filtering using threshold 0.1. Filtering for ce10 
blacklist regions and repeat regions resulted in 23,670 L1 arrest DHS peaks.  (D) Genes 
associated with L1 condition-specific noncoding DHS include many DAF-16 and 
PHA-4 targets, starvation responsive genes, and genes upregulated in the 6hr 
starved larvae compared to the embryo. Venn diagram showing number of genes 
associated with L1 condition-specific regulatory elements that are DAF16 target genes (pink; 
206 
 
from Tepper et al. 2013), PHA-4 target genes in L1 Starved (green; from Zhong et al, 2010) 
and starvation responsive genes (yellow; significant expression difference in 6hr starved 
versus 6hr fed L1 larvae, Baugh et al. 2009) and that are most upregulated in L1 starved 
larvae compared to the embryo (blue; data from Baugh et al. 2009). (E) Expression ratio 
of genes possessing L1 or embryo condition-specific noncoding DHS Boxplot 
showing the ratio of expression of genes possessing L1 (blue) or embryo (yellow) condition-
specific noncoding DHS. Ratio is measured by dividing the expression observed in 6hr L1 
starved larvae by embryo expression (data from Baugh et al. 2009). 
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